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ABSTRACT 
 
Copper and Zinc Balance in Exercising Horses 
Fed Two Forms of Mineral Supplements. (December 2006) 
Elizabeth Lynn Wagner, B.S., University of Wisconsin – River Falls; 
M.S., Texas A&M University 
Co-Chairs of Advisory Committee:  Dr. Gary D. Potter 
  Dr. Pete G. Gibbs 
 
This study was undertaken to compare the absorption and retention of copper and 
zinc when supplemented to exercising horses in the form of sulfate or organic-chelate 
mineral supplements.  Nine mature horses were used in a modified-switchback designed 
experiment consisting of seven 28-d periods.  Horses were fed a diet consisting of 50% 
coastal Bermudagrass and 50% concentrate.  All diets were balanced to meet the energy, 
protein, calcium and phosphorus requirements for horses performing moderate to intense 
exercise.  Copper and zinc supplementation varied by period.  During mineral depletion 
and repletion periods, horses respectively consumed diets with no supplemental mineral 
or Cu and Zn supplemented in the sulfate form to provide 100% of NRC (1989) values.  
In periods 4 and 7, horses were fed diets designed to provide 90% of NRC (1989) values 
for Cu and Zn supplied in the sulfate or organic-chelate forms.  Horses were subjected to 
a standard exercise test on d 23 of periods 4 and 7 followed by a 4-d total fecal and urine 
collection.  Blood samples were drawn every 28-d for determination of plasma Cu, Zn 
and ceruloplasmin concentration, and white blood cell counts and Cu,Zn-superoxide 
dismutase activity were evaluated in periods 4 and 7.  Copper and zinc balance was 
 iv
determined from feed, fecal, urine and water samples obtained during the total 
collections in periods 4 and 7. 
Copper and Zn intake and fecal excretion were greater (P<0.05) for horses 
consuming the organic-chelate supplemented diet.  Apparent Cu absorption as a percent 
of intake and retention as a percent of intake were also greater for this group.  Plasma 
Cu, Zn and ceruloplasmin concentration was not different for horses consuming the two 
mineral supplement forms. White blood cell counts and superoxide dismutase activity 
were not affected by diet treatment.  Formulation error and suspected sample 
contamination made it difficult to compare absorption and retention of Cu and Zn, but 
the use of a controlled repletion-depletion diet sequence appeared to be an effective 
experimental design component.   
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CHAPTER I 
INTRODUCTION 
 
Copper and zinc play important roles in the growth and maintenance of tissues in 
horses, including bone and hoof wall.  They have also been associated with mechanisms 
for managing oxidative stress, particularly the cytosolic enzyme superoxide dismutase 
(SOD).  These trace minerals are manufactured for feed supplementation in several 
forms, but are most commonly added to diets in sulfate or organic-chelate forms.  
Research has examined the relative bioavailability of these minerals in many livestock 
species, as evidenced by growth, tissue mineral concentration and immune function.  
Several researchers have noted significant differences in the bioavailabilities of minerals 
provided in sulfate and organic-chelate forms, while others have noted comparable 
performance.   Research in horses has not been as extensive as in other species, leaving 
much to be learned about trace mineral absorption and retention. 
Previous research from this laboratory (Wagner et al., 2005) compared the 
absorption and retention of copper and zinc in mature, idle horses, concluding that there 
were no differences in absorption among sulfate, oxide and organic-chelate forms of 
supplementation for horses in this metabolic state.  It was postulated that horses in a 
state of increased mineral demand, such as intense exercise, may be a more ideal model 
for comparing forms of trace mineral supplementation.  Research in this area has the 
__________________ 
This dissertation follows the style and format of the Journal of Animal Science.
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potential to answer several industry issues related to feed formulation.  Large scale 
producers and individual horse owners seek a mineral supplement that will provide an 
economically efficient source of trace minerals to meet requirements.  A better 
understanding of the amount of a given mineral absorbed by the horse will result in more 
accurate ration formulation, and a reduced potential for environmental pollution by over-
supplementation of minerals.   
 The objectives of this dissertation research are two-fold:  first, to compare 
absorption and retention of copper and zinc supplemented in either the sulfate or 
organic-chelate forms in a marginally-deficient diet; second, to document physiologic 
responses of plasma mineral concentrations, ceruloplasmin activity and erythrocyte SOD 
activity as horses are subjected to the experimental procedures described here-in.   
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CHAPTER II 
REVIEW OF LITERATURE 
 
Elemental copper (Cu) and zinc (Zn) are commonly added to formulated horse 
diets to correct or prevent deficiencies and a variety of related disorders.  The NRC 
(1989) established minimum requirements for these minerals of 10 ppm Cu and 40 ppm 
Zn for all classes of horses.  However, many processed feeds contain more than the NRC 
recommendations for Cu and Zn to compensate for mineral deficient forages, to ensure 
optimal absorption and utilization, or both.  Additionally, it is frequently observed that 
individual owners oversupplement their horses with these trace minerals.  Copper and Zn 
supplementation is often misunderstood, and sometimes unknowingly abused, in the 
feeding of horses.  Not only is this economically wasteful, but environmentally 
challenging, as excess mineral is excreted back into the environment.   
 Copper received most of its attention in equine research due to its role in bone 
tissue formation and strength.  Copper is required for lysyl oxidase function, a step in the 
formation of cross-links in collagen and elastin (Strause et al., 1986).  As a result, lysyl 
oxidase is an enzyme of interest in bone development and formation.  This explains why 
Cu research has been associated with developmental orthopedic diseases (DOD), 
particularly osteochondritis dissecans (Cymbaluk and Smart, 1993).  Low Cu intake has 
been implicated in the incidence of DOD (Bridges and Harris, 1988; Knight et al., 1985), 
though it should be noted that copper deficiency is only part of a complex etiology 
(Cymbaluk and Smart, 1993).  Beyond bone tissue integrity, Cu is involved in several 
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other prominent physiological processes.  Cytochrome c oxidase and Cu,Zn-superoxide 
dismutase (SOD) both require Cu for proper metabolic function (Baker and Ammerman, 
1995a).  Copper deficiency has also been associated with impaired neutrophil activity, 
tissue mitochondrial degeneration and decreased heme synthesis (Mills, 1987).   
 Zinc is also associated with bone formation in horses, though some of the 
literature has addressed the antagonistic effect high Zn intake has on Cu absorption and 
utilization in this respect (Bridges and Moffitt, 1990).  In addition to bone, epithelial 
integrity including hoof growth and quality is a focus of research in horses (Ott and 
Johnson, 2001).  Zinc serves in a wide range of capacities in the body ranging from 
enzyme cofactor to protein structural component.  Zinc works in concert with Cu in the 
activity of cytosolic SOD and also as part of the zinc-finger proteins associated with 
DNA translation and cell replication.   
 The ability of these minerals to perform their functions in the body is dependent 
upon their inclusion in the diet at appropriate concentrations and their subsequent 
absorption.  Most equine diets need supplementation of Cu and Zn in order to meet NRC 
requirements.  Mineral supplements can be divided into two groups: inorganic and 
organic-chelates.  Inorganic minerals consist of the mineral of interest bound in an ionic 
salt molecule, most commonly paired with a sulfate or oxide group.  Organic-chelates 
are minerals covalently bound to specific amino acid structures or non-descript 
proteinate complexes.   
The proposed absorption mechanisms for these two groups reflect their structural 
differences (Ashmead et al., 1985).  The inorganic salts ionize in the low pH of the 
 5
stomach and intestine, allowing the metal cations to covalently bind with integral 
membrane proteins of the intestinal mucosal cells.  The mineral is absorbed against a 
concentration gradient, relying on changes in fluid pH and competition between various 
carrier proteins to assist the cation in its journey from the intestinal lumen to the exterior 
side of the basement membrane.  Organic-chelate minerals differ in that the covalently 
bound structure formed by the mineral ion and the amino acid(s) is thought to be 
resistant to the acidic stomach environment, and is able to be absorbed intact in the small 
intestine.  Once the molecule enters the cell via amino acid or small peptide absorption 
mechanisms, the mineral is believed to be released from its ring structure by a shift in 
pH at the basement membrane of the mucosal structure.  Because the absorption of the 
organic-chelate mineral complex requires fewer steps and a less critical intestinal and 
cellular environment for its uptake than the naked mineral cations, it is believed that the 
organic-chelate is more available for absorption and incorporation into body tissues. 
Other theories regarding absorption of metal chelates have also been proposed.  
Binding affinity between the metal and organic constituents determine the characteristics 
of the chelate, including its ability to remain bound in the gastrointestinal environment 
(Kratzer and Vohra, 1988).   This can be extended to include the interaction of inorganic 
metal salts with various amino acids, proteins and digestive juices during the process of 
digestion, some of which may have such a strong binding affinity that the mineral 
becomes unavailable for absorption later.  In a review of literature on organic mineral 
sources, Greene et al. (1995) noted the possibility that the metal chelate may exchange 
the metal with other dietary constituents prior to absorption, thereby influencing the 
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absorption of several nutrients.  The authors also suggested metals already complexed in 
an organic-chelate form when entering the digestive tract may be more soluble and more 
likely to be absorbed.  In this respect, minerals originating in feedstuffs and already 
bound to organic compounds may be more available than those supplemented in the 
inorganic salt forms.  The specific mechanisms by which chelated minerals influence the 
absorption of their own metals and as well as other dietary constituents are still not 
understood, and would be an area for additional research.  
Generally the normal absorptive mechanism of trace minerals depends on the 
metal’s ability to chelate or bind with proteins, peptides and amino acids in the lumen of 
the intestine (Menard and Cousins, 1983).  Copper is absorbed by several mechanisms in 
mammalian cells.  Harris (2001) reviewed several identified copper uptake mechanisms, 
including the copper transport (Crt-1) protein as well as the natural resistance-associated 
microphage protein (Nramp2) system.  Nramp2 is involved in the transport of a number 
of divalent cations including Cu2+  and Zn2+, and has also been referred to as divalent 
metal transporter (DMT-1) or divalent cation transporter (DCT-1) for this reason.  In the 
case of Zn, the ZIP family and DCT-1 transporters appear to be the best candidates for 
transporting the Zn2+ into the cell, though the exact metabolic pathway is still unknown 
(Harris, 2002).   
 In vivo experimentation in various species of animals has yielded mixed results 
depending on the amount of mineral supplemented, the species model, and the actual 
forms of mineral supplement.  Baker et al. (1991) observed similar bioavailability 
comparisons with CuO, CuSO4 and Cu-lysine when examining Cu concentrations in 
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chick livers.  Rats supplemented Cu as Cu-proteinate or Cu-lysine had higher 
concentrations of Cu in the liver, spleen and heart compared to those supplemented with 
CuSO4 (Du et al., 1996). Coffey et al. (1994) also noted mixed results from a series of 
experiments studying CuSO4 and Cu-lysine fed to growing swine at different 
supplementation rates, but concluded that Cu as Cu-lysine was as effective as, and in 
some cases more than, CuSO4 in enhancing feed and growth performance.  Schell and 
Kornegay (1996) observed higher serum Zn concentrations with ZnSO4 than ZnO, with 
intermediate values for Zn-methionine and Zn-lysine in weanling pig diets.  Sheep 
supplemented with Zn-lysine had a greater accumulation of Zn in the liver, kidney and 
pancreas than Zn-methionine, ZnSO4 and ZnO, while Zn-methionine was not 
significantly different from ZnSO4 when comparing all four treatments (Rojas et al., 
1995).   
 In general, the oxide supplement form is less available or as available as mineral 
supplemented as the sulfate (Baker and Ammerman, 1995a, b).  Studies comparing 
organic-chelates and sulfates are less conclusive, due in part to the wide variability in 
organic-chelate forms.  This can be attributed to differences in binding affinity with 
respect to the chelating compound.  Metal amino acid complexes, such as Cu-lysine, 
consist of a specific mineral bound to a specific amino acid whereas mineral bound to a 
proteinate complex could be bound to a variety of constituent amino acids with various 
binding affinities (Greene et al., 1995).   
 Research illustrating differences in trace mineral supplementation in horses has 
not been as thorough as that seen in other species, but does reflect the inconsistent 
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results observed elsewhere.  Siciliano et al. (2001a) supplemented one group of mares to 
meet NRC requirements with CuSO4, MnO and ZnSO4, and a second group received one 
half of the supplement in the same inorganic forms and the other half from Cu-lysine, 
Mn-methionine and Zn-methionine. No difference in liver mineral concentration or 
immune response was noted between the two groups.  Ott and Asquith (1994) noted no 
differences in mare reproductive performance between broodmares supplemented with 
inorganic or a combination of inorganic and proteinated trace minerals, no differences in 
foal growth measurements and no differences in foal estimated bone mineral content.  
An increase in foal serum Zn and Cu was observed in the organic and inorganic 
supplementation group, though the response was thought to result from foals consuming 
the mares’ concentrate.  Ott and Johnson (2001) reported that yearlings supplemented 
with a proteinate trace mineral mix including Cu, Mn and Zn had greater hoof growth 
than yearlings supplemented with an inorganic supplement, but saw no differences in 
hoof strength or skeletal growth characteristics.  Siciliano et al. (2001b) did not observe 
any significant differences in hoof wall growth rates, hardness, tensile strength or trace 
mineral content between mature horses fed an inorganic Cu, Mn and Zn supplement and 
those fed a supplement consisting of half inorganic and half organic sources.  In 
exercised yearling geldings, there was no difference in radiographic bone aluminum 
equivalence measurements or carboxyterminal propeptide of type I procollagen 
concentrations in horses receiving an unsupplemented diet, an inorganic Cu and Zn 
supplemented diet or supplemented with an inorganic-organic blend (Baker et al., 2003). 
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 Mineral balance studies in horses have also yielded mixed results.  In work with 
yearling geldings, Miller et al. (2003) fed an unsupplemented concentrate or a 
concentrate containing approximately 50 ppm Cu and 200 ppm Zn as CuSO4 and ZnO or 
with 45% of the supplemental mineral replaced by an organic source.  Copper 
digestibility was greater in horses fed the organic supplement, as was mean apparent Cu 
balance and Cu balance as a percent of intake.  Apparent Zn balance was also greater for 
yearlings consuming the organic supplement, though this concentrate contained  
216.6 ppm Zn compared to 189.9 ppm in the inorganic supplemented concentrate.  
Baker et al. (2005) used mature horses in a study of similar diet treatment design, with 
concentrates containing 66.6 ppm Cu and 373.7 ppm Zn in the inorganic supplemented 
treatment and 53 ppm Cu and 305 ppm Zn in the inorganic-organic blend treatment.  
Apparent Cu digestibility and balance was greater for horses consuming the inorganic 
mineral source, as was apparent Zn digestibility and balance.  Wagner et al. (2005) used 
adult Miniature Horses to compare absorption and retention of Cu and Zn when 
supplemented in the sulfate, oxide or organic-chelate forms.  Horses consuming 13.5 
ppm Cu and 56.2 ppm Zn had no difference in absorption or retention, both apparent and 
as a percent of intake.  It should be noted that this project used a 10 d diet adaptation 
prior to total collection compared to longer adaptation periods in other studies.   
 Copper and zinc balance and status can be difficult to measure in horses.  When 
fed in excess of body needs, both minerals are excreted through the bile in an 
unavailable form in the feces (Chesters, 1997; Harris, 1997).  Work with bile-duct 
cannulated ponies given intravenous doses of 64Cu also demonstrated the excretion of 
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excess Cu through the bile, where 70.7% of the radioactive dose was recovered from the 
bile compared to 3.6% from the feces after 5 d of collection (Cymbaluk et al., 1981).  
Hoyt et al. (1995) fed Miniature Horses 76.6, 168.1, 389.5 and 606.8 mg Zn/100 kg BW, 
and reported urinary Zn excretion of 0.8 to 1.2 mg/100 kg BW across all treatments.  
 Many researchers have attempted to define normal plasma and serum 
concentrations of Cu and Zn in an effort to establish a diagnostic reference for 
identifying deficiency.  Researchers in the United Kingdom reported mean serum 
concentrations of  0.79 ± 16 μg/ml Cu and 1.70 ± 54 μg/ml Zn for stabled horses, and 
1.01 ± 26 μg/ml Cu and 1.11 ± 45 μg/ml Zn for pastured horses (Stubley et al., 1983).  In 
an Australian study with apparently normal horses, stabled Thoroughbreds had plasma 
concentrations of 0.76 ± 0.18 μg/ml Cu and 0.56 ± 0.14 μg/ml Zn (Auer et al., 1988).  
These values were lower than those reported by Hintz (1982), where the “normal” range 
for North American horses was defined as 0.80 μg/ml to 1.20 μg/ml for Cu and 0.55 
μg/ml to 0.80 μg/ml for Zn.  Cymbaluk et al. (1986) documented plasma Cu and Zn 
values of 22.5-28.3 μmol/L and 11.7-13.5 μmol/L, respectively, in yearlings on various 
feeding trials.  Plasma Cu concentrations reflected liver Cu content, but were not directly 
related to dietary Cu intake.  Liver Zn concentrations were not different across a range of 
dietary Zn intakes, but there was no correlation between liver Zn content and plasma Zn 
values.  Ralston (1992)  reported serum concentrations of 1.03-1.66 ppm Cu and 0.60-
0.79 ppm Zn in horses with varying trace mineral intakes, but noted that Cu and Zn 
content of feed alone did not explain the variation observed.  
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 Testing for the concentration or activity of Cu or Zn specific blood-borne 
proteins may be the least invasive technique for examining bioavailability.  These 
indicators are examined in conjunction with plasma or serum mineral concentrations.  
Two such proteins are ceruloplasmin and Cu,Zn-superoxide dismutase.  Both proteins 
have been implicated in antioxidant activity and inflammatory responses. 
 Seventy-three percent of plasma copper is found in the ceruloplasmin protein 
(Auer et al., 1988).  In that respect, ceruloplasmin has been used as an evaluative 
measure in a variety of animals, including horses (Bingley and Dick, 1969; Milne et al., 
1991).  Ceruloplasmin is important not only as the main Cu carrier in the blood, but also 
for its role in a variety of oxidative reactions in the body.  Ceruloplasmin is responsible 
for the oxidation of ferrous iron to the ferric state, making it readily available for binding 
the transferrin transport protein (Cranfield et al., 1979).  The anti-inflammatory and anti-
oxidant activities of ceruloplasmin have been reviewed (Auer, 1989).  Ceruloplasmin has 
also been classified as an acute phase protein that increases in concentration in the 
intermediary or later phases of acute inflammation (Okumura et al., 1991). 
 Unlike plasma or serum Cu concentrations, ceruloplasmin concentrations in 
horses are not as well documented.  In a sampling of 83 stabled Thoroughbreds, the 
mean plasma ceruloplasmin Cu concentration was 0.56 ± 0.14 μg/ml (Auer et al., 1988).  
Bingley and Dick (1969) reported 23.3 mg/100ml ceruloplasmin and 0.93 μg/ml total 
plasma Cu in a donkey.  Ceruloplasmin oxidase activity in a group of Thoroughbreds 
was 23.7 U/ml (SD ± 6.0 U/ml), and had a linear relationship with the serum Cu 
concentration (Smith et al., 1983).  It should be noted that assays, assay conditions and 
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expression of measurement are not consistent among research presented in this literature 
review, and therefore a clear comparison of ceruloplasmin values may be difficult to 
establish. 
 Like ceruloplasmin, superoxide dismutase (SOD) has been studied in conjunction 
with plasma trace mineral concentrations.  There are two forms of SOD, a cytosolic 
isoform containing Cu and Zn (Cu,Zn-SOD), and a mitochondria-predominant isoform 
with manganese (Mn-SOD) (Minatel and Carfagnini, 2000).  Erythrocyte Cu,Zn-SOD 
lends itself well to assessment of SOD activity as it pertains to Cu and Zn status, and is 
the isoform examined in this review of literature.  Superoxide dismutase is considered a 
preventative anti-oxidant as it functions by catalyzing the conversion of the superoxide 
free radical (O2·) into hydrogen peroxide (H2O2), which is then further reduced by 
catalase or glutathione peroxidase (Auer, 1989).   
 It is thought that increased oxygen consumption during exercise in horses creates 
oxidative stress, including the formation of free radicals and subsequent peroxidation of 
membranes (Balogh et al., 2001).  Balogh et al. (2001) observed no change in SOD 
activity in horses competing in a pentathlon contest even though there were elevated 
plasma lipid peroxide levels 24 h after exercise.  Ji et al. (2001) reported no significant 
changes in SOD activity in response to acute exercise when measured at rest and at 2 
and 30 minutes following 12 min exercise.  The authors concluded there was sufficient 
antioxidant capacity to handle the exercise-induced oxidative stress.  Greater SOD 
activity has been observed in horses fed Zn and Cu deficient diets, possibly as 
compensation for decreased levels of Cu, Zn and ceruloplasmin (Górecka et al., 1999).  
 13
Copper and zinc absorption and subsequent incorporation into SOD in exercising horses 
may have important implications for performance horses.   
 Also of concern in performance horses is the ability to summon an immune 
response while subjected to a stressful work and travel environment.  Immune function 
can be classified as one of two forms:  innate and acquired.  Innate, or native, immunity 
is composed of mechanisms in place prior to an infection, ready to respond in a similar 
manner to repeated infections.  This system relies on a number of components, including 
the phagocytic neutrophils and macrophages, to attack microbes as soon as they are 
presented.  Acquired, or adaptive, immunity develops as a response to infection, 
adapting to individual circumstances.   It may take several days for an adaptive response 
to be mounted, but the response is specific to the microbe presented.  Responsive cells 
include the antibody producing B-lymphocytes of humoral immunity and the T-
lymphocytes associated with cell-mediated immunity (Abbas and Lichtman, 2005).   
 Copper is involved in many aspects of immune function, and immunity can be 
impaired even when other indicators of Cu status appear normal (Percival, 1998).  
Copper deficiency has been implicated in changes in innate immune responses in cattle, 
including neutrophil function (Minatel and Carfagnini, 2000).  However, Arthington et 
al. (1995) subjected heifers to copper depletion and subsequent repletion with CuSO4 or 
Cu-proteinate and noted no change in neutrophil bactericidal function or lymphocyte 
blastogenesis using in vitro assays.  Steers fed organic or inorganic sources of Cu at or 
above recommended concentrations had no difference in bovine rhinotracheitis antibody 
titers (Rhoads et al., 2003).  Copper supplementation as either CuSO4 or Cu-Lys had no 
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effect on antibody titers, cell-mediated immune response or  in vitro lymphocyte 
blastogenesis in feedlot steers (Ward et al., 1993).   
 Like Cu, Zn also has strong ties to immune function.  A review by Shankar and 
Prasad (1998) noted that Zn is crucial for both development and function of neutrophils 
as well as the development of acquired immunity.  Livestock studies comparing 
supplementation forms have had difficulty in defining a superior supplement form using 
this study parameter.  In vitro lymphocyte activity was not different in cattle 
supplemented Zn in the oxide or organic forms (Kincaid et al., 1997; Spears and Kegley, 
2002).  Kegley et al. (2001) compared immune function in calves fed an unsupplemented 
diet as well as those with supplemental Zn from sulfate or amino acid-complex sources.  
There was no difference in total white blood cell count among the three treatment 
groups, though animal fed the amino acid-complex supplement had higher antibody 
titers for bovine syncytial virus.   
 In studies where both Cu and Zn are supplemented, analyses of immune response 
also had mixed results.  Organically supplemented heifers had greater total Ig 
concentrations than those receiving a sulfate-based mineral supplement 21 d following 
an immune challenge with porcine red blood cells, even though plasma Cu and Zn 
concentrations were not different (Ahola et al., 2005a).  Calves from these heifers were 
used in a subsequent study, and were maintained on the same supplement form as their 
dams through finishing (Ahola et al., 2005b).  There was no difference in cell-mediated 
immune response to intradermal injection of phytohemagglutinin among animal 
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receiving no supplementation or those fed inorganic or organic supplemented diets, nor 
was there a difference in IgG, IgM and total Ig among treatments.   
 There is a limited amount of work examining trace mineral balance and immune 
function in horses.  In a companion study to work previously reviewed herein (Siciliano 
et al., 2001b), horses were inoculated with porcine red blood cells to elicit a primary 
humoral immune response (Siciliano et al., 2003). Mean total antibody titer was greater 
7- and 14-d post-innoculation for horses consuming an organic trace mineral supplement 
than those on the inorganic supplement.  Mean IgM titer was also greater for organically 
supplemented horses though there was no difference in IgG titer.  Finding an appropriate 
test for immune function can be a challenge in equine studies due to limited animal 
numbers per treatment and length of time for feeding periods or recovery from immune 
challenges.  Because T-cell function is Zn dependent, a hematological analysis including 
differential white cell count and lymphocyte count is the starting point for examining 
differences in immune function (Tizzard, 2005).   
 Copper and Zn balance is just one way to examine the availability of these 
minerals from various supplement forms when fed to horses.  Equine studies rarely 
combine this information with other indicators of Cu and Zn status, such as plasma 
mineral profiles and function of Cu- and Zn-dependent enzymes or systems.   
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CHAPTER III 
MATERIALS AND METHODS 
 
Eight mature mares and one gelding of various breeds (two Arabians, two Paints 
and five Quarter Horses) were used in a modified switchback experimental design.  
Horses were maintained at the Texas A&M University Horse Center, following 
procedures in the approved Animal Use Protocol. Prior to and during the experiment, 
horses were dewormed and vaccinated in accordance with facility procedures.  Horses 
were blocked by age and breed and randomly assigned to one of two groups for the 
switchback periods.   
 The experiment was conducted in seven 28-d periods as outlined in Table 1.  
Periods 1 and 2 served as exercise conditioning periods, where horses were acclimated 
to the mechanical walker and treadmill as well as adapted to the exercise demands of the 
subsequent periods.  The concentration of dietary Cu and Zn changed each period, such 
that the horses were subject to a standardized repletion/depletion cycle prior to receiving 
the appropriate experimental diet.   
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Table 1.  Exercise and Diet Treatments by Period 
Period Exercise Diet 
1 
 
Conditioning 
 
Basal diet  (No Cu and Zn 
Supplementation) 
2 
 
Conditioning 
 
Repletion Diet (Cu and Zn 
at 100% of NRC) 
3 
 
Standard 
Workload 
Basal diet 
 
4 
 
Standard 
Workload 
Experimental Diet  (Cu 
and Zn at 90% of NRC) 
5 
 
Standard 
Workload 
Repletion Diet 
 
6 
 
Standard 
Workload 
Basal diet 
 
7 
 
Standard 
Workload 
Experimental Diet  
 
 
Diet Formulation 
Horses were offered a 50:50 concentrate:hay diet at 1.5-2% of BW divided 
between two feedings daily.  During the first three periods, the amount of feed offered 
was adjusted such that the horses maintained a body condition suitable for their 
workload, and this amount was held constant for the remainder of the project.   The diet 
was formulated to provide DE at 175% of maintenance, with CP, Ca and P balanced to 
appropriate DE:nutrient ratios (NRC, 1989).  Other nutrients were supplied to meet or 
exceed NRC (1989) requirements.  Diet Cu and Zn concentrations varied by period, such 
that the horses received no supplemental Cu and Zn (basal/depletion diet), 100% of the 
NRC (repletion diet), or the experimental diet of Cu and Zn supplemented to meet 90%  
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Table 2. Background Ration Formulations       
Basal (Depletion) Diet       
  Provided on a Dry Matter Basis 
Ingredient 
% of Diet 
As Fed 
DE 
(Mcal) 
% 
CP 
Ca 
% P % 
Cu 
(ppm) 
Zn 
(ppm) 
Coastal Bermudagrass 50.0000% 1.05 5.90 0.22 0.12 3.00 14.00
Corn 27.1000% 1.04 2.82 0.01 0.08 1.14 5.96
Oats 8.0000% 0.26 1.06 0.01 0.03 0.54 3.12
Wheat Mids 5.0000% 0.17 0.93 0.01 0.05 0.90 5.45
Soybean Meal 5.0000% 0.18 2.50 0.02 0.04 1.12 0.65
Vegetable Fat 4.0000% 0.36 0.00 0.00 0.00 0.00 0.00
Calcium Carbonate 0.4000%   0.16    
Salt 0.5000%       
Total  3.05 13.20 0.42 0.32 6.69 29.18
        
Repletion Diet        
  Provided on a Dry Matter Basis 
Ingredient 
% of Diet 
As Fed 
DE 
(Mcal) 
% 
CP 
Ca 
% P % 
Cu 
(ppm) 
Zn 
(ppm) 
Coastal Bermudagrass 50.0000% 1.05 5.90 0.22 0.12 3.00 14.00
Corn 27.0966% 1.04 2.82 0.01 0.08 1.14 5.96
Oats 8.0000% 0.26 1.06 0.01 0.03 0.54 3.12
Wheat Mids 5.0000% 0.17 0.93 0.01 0.05 0.90 5.45
Soybean Meal 5.0000% 0.18 2.50 0.02 0.04 1.12 0.65
Vegetable Fat 4.0000% 0.36 0.00 0.00 0.00 0.00 0.00
Calcium Carbonate 0.4000%   0.16    
Copper Sulfate 0.0012%     3.05  
Zinc Sulfate 0.0022%      8.00
Salt 0.5000%       
Total   3.05 13.20 0.42 0.32 9.74 37.18
        
 
of the NRC recommendations (Tables 2 and 3).  In this manner, horses were subject to 
controlled repletion and depletion of body mineral stores prior to feeding of a marginally 
deficient Cu and Zn diet, so that a systemic demand for Cu and Zn existed during the 
feeding of the experimental diet.  Mineral supplementation in the repletion phases was 
provided by CuSO4 and ZnSO4, whereas supplementation in the experimental phases  
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Table 3. Experimental Ration Formulations       
Sulfate Supplemented Diet       
  Provided on a Dry Matter Basis 
Ingredient 
% of Diet 
As Fed 
DE 
(Mcal) 
% 
CP 
Ca 
% P % 
Cu 
(ppm) 
Zn 
(ppm) 
Coastal Bermudagrass 50.0000% 1.05 5.90 0.22 0.12 3.00 14.00
Corn 27.0966% 1.04 2.82 0.01 0.08 1.14 5.96
Oats 8.0000% 0.26 1.06 0.01 0.03 0.54 3.12
Wheat Mids 5.0000% 0.17 0.93 0.01 0.05 0.90 5.45
Soybean Meal 5.0000% 0.18 2.50 0.02 0.04 1.12 0.65
Vegetable Fat 4.0000% 0.36 0.00 0.00 0.00 0.00 0.00
Calcium Carbonate 0.4000%   0.16    
Copper Sulfate 0.0008%     2.04  
Zinc Sulfate 0.0012%      4.36
Salt 0.5000%       
Total  3.05 13.20 0.42 0.32 8.73 33.54
        
Organic-Chelate Supplemented Diet      
  Provided on a Dry Matter Basis 
Ingredient 
% of Diet 
As Fed 
DE 
(Mcal) 
% 
CP 
Ca 
% P % 
Cu 
(ppm) 
Zn 
(ppm) 
Coastal Bermudagrass 50.0000% 1.05 5.90 0.22 0.12 3.00 14.00
Corn 27.0850% 1.04 2.82 0.01 0.08 1.14 5.96
Oats 8.0000% 0.26 1.06 0.01 0.03 0.54 3.12
Wheat Mids 5.0000% 0.17 0.93 0.01 0.05 0.90 5.45
Soybean Meal 5.0000% 0.18 2.50 0.02 0.04 1.12 0.65
Vegetable Fat 4.0000% 0.36 0.00 0.00 0.00 0.00 0.00
Calcium Carbonate 0.4000%   0.16    
Copper-Lysine 0.0040%     2.00  
Zinc-Methionine 0.0110%      4.40
Salt 0.5000%       
Total   3.05 13.20 0.42 0.32 8.69 33.58
        
 
was provided either by the sulfate forms or organic-chelate sources in the form of Cu-
lysine and Zn-methionine (Zinpro Corp., Eden Prairie, MN).  All concentrates were 
manufactured by Martindale Feed Mill, Valley View, TX. 
Daily hay and concentrate amounts were divided into two separate feedings and 
offered at 600 and 1800 h.  Horses were fed individually in concrete-floored stalls from 
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non-metal containers.  Refusals, if any, were weighed and recorded.  When not being 
fed, horses were group-housed in dry-lot pens with ad libitum access to tap water.  Pens 
were cleaned twice daily to prevent coprophagy.   
 
Exercise 
 During the standard workload phases, horses were exercised on a mechanical 
walker to create a DE demand of 175% of maintenance.  Experimental workload was 
determined using the formula DE (Mcal/kg) = 5.97 + 0.021W + 5.03X – 0.48X2, where 
W is the body weight (kg) and X = (wt of horse, rider and tack) x km x 10-3 (Anderson et 
al., 1983).  The horses were conditioned to perform an average daily workload of 3.93 
kg*km*10-3 with a DE demand of 28.8 Mcal.  Horses were exercised on the mechanical 
walker five days a week, with a workout consisting of 3 min warm-up at the walk, 10 
min at 200 m/min, three 7 min bouts of cantering at 333 m/min, 10 min trotting and a 3 
min cool down at the walk, with 3 min walk breaks between trotting and cantering bouts, 
for a total of 10.99 km of non-walking exercise.   
 
Standard Exercise Test
 On d 24 of periods 4 and 7, horses completed a standardized exercise test (SET).    
Prior to the SET, horses were fitted with jugular catheters and heart rate monitors 
(EquiPulse, San Jose, CA) to facilitate data and sample collection.  The SET was 
performed on the treadmill at a 1.9% slope or on the mechanical walker when 
mechanical failure prevented use of the treadmill.  The SET was designed to mimic the 
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typical exercise session.  It consisted of 3 min warm-up at the walk, 10 min trot at 200 
m/min, 3 min walking, 7 min cantering at 360 m/min, 3 min walking, 7 min cantering at 
333 m/min, 3 min walking, 7 min cantering at 333 m/min, 3 min walking, 10 min 
trotting at 200 m/min and a 5 min hand-walking cool down.  Horses traveled 11.18 km 
during non-walking exercise, for an approximate workload of 5.59 kg*km*10-3.  Heart 
rates were monitored to ensure the workload was within normal parameters.  Rates were 
recorded prior to the start of the test, following the warm-up walk, and upon completion 
of the trotting and cantering bouts.  Heart rates were also recorded at 1, 2 and 5 min 
post-exercise, at which point all horses had returned to pre-exercise, resting heart rates. 
 
Mineral Intake and Balance  
Random samples of hay and concentrate were obtained throughout the 
experiment for determination of Cu and Zn intake during the repletion and depletion diet 
periods. 
A 4-d total collection for determination of Cu and Zn balance was conducted d 
25 through d 28 of periods 4 and 7.  Horses were confined to individual tie stalls, and 
stood on rubber mats so as to lessen physical stress to the legs from the concrete 
flooring.  Horses were fitted with a urine collection harness to allow for separate and 
total collection of feces and urine.  Feed and water was offered from non-metal 
containers.  Frequent inspections of horses during collection reduced the risk of sample 
contamination, and included thorough sweeping of floor surfaces to remove dirt and 
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hair.  In order to alleviate the effects of confinement, horses were walked and lightly 
trotted for 30-45 min on a mechanical walker each day of the total collection.   
Concentrate and hay samples were obtained daily at feeding time during the total 
collection and stored in plastic bags for later analyses.  Water intake was measured and 
recorded.  One water sample per collection period was collected from the same source as 
the horses’ drinking water.  The samples were stored in Nagalene tubes and frozen at -
20ºC until further analyses.  Daily concentrate and hay samples were collected and 
stored in plastic bags.   
Immediately upon defecation, fecal samples were placed in plastic buckets.  
Every 3 h, feces for each horse were weighed and recorded, with a 10% aliquot added to 
a daily collection bag.  Contaminated fecal matter was weighed separately and weight 
recorded, but not added to the daily sample.  Workers changed latex gloves between 
horses, and cleaned plastic weighing equipment between samples to prevent cross-
contamination.  Daily fecal samples were stored in plastic freezer-quality bags and 
frozen at -20ºC for later analyses.   
Urine was collected after every void to prevent contamination.  Urine volume 
was measured in a plastic graduated cylinder and recorded, with a 10% aliquot added to 
a daily collection bottle.  Any contaminated urine was measured and volume recorded, 
but not added to the daily composite.  Urine was initially refrigerated in mineral-free 
collection bottles.  At the end of each collection period, daily urine samples were 
strained through three layers of cheesecloth and individually frozen at -20ºC in Nagalene 
tubes until further analyses.  Collection and measuring equipment was rinsed with 
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distilled water between uses, and thoroughly cleaned and rinsed between collection 
periods. 
In the laboratory, feed and fecal samples were dried at 65ºC for a minimum of  
72 h and ground in a Wiley mill with a 2mm screen.  Dried samples were stored in 
sealed, mineral-free plastic containers.  Composites of hay, concentrate and fecal 
samples were generated from individual daily samples to provide one sample per horse 
per treatment. 
Copper and zinc concentration of feed, fecal, urine and water samples was 
determined by the Soil, Water and Forage Testing Laboratory at Texas A&M University, 
College Station, TX.  Prior to shipment to the lab, submitted samples were placed in 
mineral-free Nagalene tubes, and assigned a sample ID number so as to blind laboratory 
technicians to sample identity.  Corn stalk standard samples were similarly processed, 
labeled, and inserted randomly among the experiment samples to serve as control 
samples.   
 
Blood Sampling and Analyses 
Blood samples were obtained prior to the morning feeding at various points 
during the research project.  Blood samples were drawn by venipuncture using 
heparinized tubes.     
Plasma for determination of Cu and Zn concentration was harvested from 
samples obtained on the first day of each period and at the completion of the experiment.  
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Plasma was frozen at -20ºC and sent to the Texas Veterinary Medical Diagnostic 
Laboratory (TVMDL) in College Station, TX for Cu and Zn analyses.   
Ceruloplasmin concentration was determined from plasma obtained on the first 
day of each period and at the completion of the experiment.  Because ceruloplasmin is 
an acute-phase protein responsive to inflammation, an additional sample was drawn the 
morning of d 24 of periods 4 and 7 prior to the stresses of the exercise test and total 
collection.  Plasma was harvested and stored at -20ºC until analyzed.  Ceruloplasmin 
concentration as indicated by oxidase activity was measured by the colorimetric method 
described by Bingley and Dick (1969), at pH 6.4 as reported by Milne et al. (1991).  In 
this procedure, 1 ml of 0.1% p-phenylenediamine (PPD) solution, dissolved in 0.1 M 
sodium acetate buffer and pH adjusted, was added to 100 μL plasma. After incubation at 
37ºC for 15 min, the oxidation reaction was stopped by the addition of 5 ml of a 0.1% 
sodium azide solution.  Absorbance was read at a wavelength of 525 nm on an 
ultraviolet spectrophotometer (Pharmacia LKB Ultraspec III).  A control was included in 
each run to correct for inherent colorimetric change of the PPD solution.  Ceruloplasmin 
concentration was determined by the formula -1.7 + 150(corrected absorbance) = 
ceruloplasmin mg/100mL.  
Samples for SOD activity analysis and hemoglobin concentration were drawn on 
the first day of periods 4 and 7 as well as at several points during the SET.  For the SET, 
blood was drawn prior to exercise, upon completion of the final canter and trot phases of 
the test and at 30 and 60 min after the last trot phase.  Erythrocytes were harvested, 
processed and frozen at -20ºC for later analyses.  Erythrocyte SOD activity was analyzed 
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using RANSOD kits (RANDOX Laboratories Ltd., Antrium, UK).  Hemoglobin 
concentration, used in determining SOD activity, was performed by TVMDL as part of 
the complete blood chemistry analysis. 
Blood samples for white blood cell analyses were obtained on d 1, d 24 and upon 
completion of periods 4 and 7.  Complete blood chemistry was performed by TVMDL, 
including total white blood cell count (WBC), differential white cell count and 
lymphocyte count.   
 
Statistical Analyses
 Resulting data were using STATA statistical software.  Differences were 
considered significant at P<0.05.  Mineral balance was evaluated using analysis of 
variance (ANOVA) procedures appropriate for the switchback design.  Plasma mineral 
and ceruloplasmin concentrations were compared during the background and washout 
periods using paired t-tests when horses were subject to repeated diet treatments.  
Analysis of variance was used to evaluate plasma mineral and ceruloplasmin 
concentrations during the initial background periods as well as to compare response to 
the experimental diets in periods 4 and 7.   Heart rate and response of SOD to exercise 
were analyzed by linear regression.  Superoxide dismutase activity at rest was compared 
by ANOVA.  White blood cell count data were analyzed by ANOVA, and paired t-tests 
were utilized in comparing means on the first day of periods 4 and 7. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
 
 One horse developed hind limb lameness during period 5 requiring several 
months of rest, and was removed from the project.  All other horses remained sound and 
healthy through the course of the project.   
One horse refused to consume concentrate during the final total collection.  
Consequently, all intake and mineral balance data for this horse during period 7 were 
omitted from statistical analyses.  Data from this horse regarding the SET and blood 
sampling from this period were included in all other analyses. 
 
Repletion and Depletion Diet Periods 
Mean mineral concentrations of the diets on a dry matter basis are illustrated in 
Table 4.  During the depletion phases, the diet contained 50-56% of NRC (1989) values 
for Cu and 78-83% of Zn.  Zinc content of the repletion diet was slightly greater than the 
requirement of 40 ppm, analyzing at 102-113% of the target value.  Copper content of 
the repletion diet varied during the course of the project.   During the first repletion 
period, Cu concentration of the diet was similar to the requirement of 10 ppm.  Copper 
concentration of the diet fed during the second repletion period was 7.05 ppm, or 71% of 
the requirement.  At the onset of the project, sufficient quantities of feed were ordered 
such that all depletion and repletion period concentrates should have come from single,  
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Table 4. Mineral Concentrations of 
Depletion and Repletion Diets 
  Dry Matter Basis 
Period Diet Cu (ppm) Zn (ppm) 
1 Depletion 5.05 33.35 
2 Repletion 10.75 45.50 
3 Depletion 5.05 33.35 
5 Repletion 7.05 42.35 
6 Depletion 5.60 31.00 
    
 
uniform batches.  However, rodent damage to feed bags necessitated re-ordering of the 
repletion and depletion phase concentrates during the study.  Variations in mineral  
concentration can be attributed to inherent variation in trace mineral content in grains 
and forages. 
 
Feed Intake and Mineral Consumption from Experimental Diets 
Mean mineral concentration of the sulfate diet was 6.28 ppm Cu and 35.99 ppm 
Zn on a dry matter basis, while the chelate diet contained 23.62 ppm Cu and 90.67 ppm 
Zn on a dry matter basis.  Mineral content of the diets was significantly different.  A 
calculation error in the formulation of the organic-chelate diet resulted in the Cu-Lys and 
Zn-Met being included at ten times the rate they should have been added.  Further 
complicating the differences between expected and observed dietary mineral 
concentrations was variation in the mineral content of the hay.  All hay was purchased in 
one lot and sampled prior to the beginning of the project for the purpose of diet 
formulation.  Pre- and post-project hay analysis was performed by the same laboratory.  
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The initial hay samples tested 6 ppm Cu and 28 ppm Zn on a dry matter basis, whereas 
grab samples taken throughout the project, including total collections, averaged 4.5 ppm 
Cu and 24.14 ppm Zn.   
Daily dry matter consumption by horses averaged 1.52% of body weight during 
periods 4 and 7.  Dry matter digestibility averaged 60.39% across treatment groups in 
these periods.   
 
Water Intake and Mineral Consumption 
Daily water intakes for each horse are noted in Appendices 1 and 2.  Mineral 
composition of the tap water during periods 4 and 7 averaged 0.156 ppm Cu and 0.380 
ppm Zn, representing 3.97% of daily Cu intake and 1.94% of daily Zn intake.   
 
Absorption and Retention of Minerals
Balance data for each horse in periods 4 and 7 are in Appendices 1 and 2.  Total 
daily mineral intake, including mineral consumed from both feed and water, was used to 
calculate balance data.  The mean daily Cu and Zn absorption and retention for horses 
consuming the sulfate and organic-chelate experimental diets are illustrated in Tables 5 
and 6. 
Copper intake and fecal excretion was greater for horses consuming the organic 
chelate diet.  While apparent absorption was not different between treatments, 
differences in absorption as a percent of intake reflected the disparity in Cu intake 
between diets.  Urinary Cu excretion and apparent retention were not different.  
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Table 5. Apparent Daily Copper Absorption and Retention 
  Treatment 
  Sulfate Organic Chelate Total 
    Mean SEM Mean SEM Mean SEM 
Intake, mg/100kg BW 10.53* 0.62 35.73* 1.27 24.71 3.31 
Fecal Excretion, mg/100kg BW 13.15* 0.66 38.59* 1.89 27.46 3.43 
Absorbed, mg/100kg BW -2.62 0.63 -2.85 0.89 -2.75 0.55 
 % of intake -26.14* 6.83 -7.71* 2.29 -15.77 3.91 
Urinary Excretion, mg/100kg BW 3.43 1.02 3.46 1.50 3.45 0.92 
Retained, mg/100kg BW -6.05 1.19 -6.32 1.61 -6.20 1.01 
 % of intake -57.94* 10.74 -17.21* 4.19 -35.03 7.26 
  % of absorbed 331.10 102.31 93.19 182.08 197.27 112.72 
*Row means differ (P<0.05)       
 
Table 6. Apparent Daily Zinc Absorption and Retention 
  Treatment 
  Sulfate Organic Chelate Total 
    Mean SEM Mean SEM Mean SEM 
Intake, mg/100kg BW 57.72* 2.02 136.48* 5.17 102.02 10.51 
Fecal Excretion, mg/100kg BW 72.14* 3.56 153.65* 5.38 117.99 10.95 
Absorbed, mg/100kg BW -14.43 4.54 -17.17 6.11 -15.97 3.86 
 % of intake -26.34 9.04 -13.63 5.23 -19.19 5.02 
Urinary Excretion, mg/100kg BW 3.53 0.77 3.69 0.52 3.62 0.43 
Retained, mg/100kg BW -17.96 4.81 -20.85 6.21 -19.58 3.97 
 % of intake -32.48 9.67 -16.34 5.32 -23.40 5.40 
  % of absorbed 41.05 99.10 114.44 15.55 82.33 43.35 
*Row means differ (P<0.05)       
 
Copper retention between the diets was different when expressed as a percent of intake 
but not as a percent of the mineral absorbed.  There was a trend (P=0.07) for a period 
difference and a significant effect of period by diet interaction for Cu absorbed as a 
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percent of intake, though no other significant differences or trends were noted for period 
or period by diet interactions regarding Cu balance. 
 Similarly, zinc intake and fecal excretion were greater for horses consuming the 
organic chelate supplemented diet.  No other differences were found between the diets 
for absorption, absorption as a percent of intake, retention, retention as a percent of 
intake or retention as a percent of Zn absorbed.  There was a significant difference by 
period for urinary Zn excretion, though no other period differences or trends were 
observed.  Trends toward differences in period by diet interactions were observed for Zn 
absorption (P=0.06) and Zn retention (P=0.08) but not for other measures of Zn balance. 
 The low absorption values would normally indicate horses in a state of negative 
mineral balance, or deficient mineral intake.  However, horses on the organic-chelate 
diet were consuming two to three times the NRC recommended intakes for Cu and Zn.  
Furthermore, the high urinary excretion of these minerals would normally indicate that 
horses were in a positive mineral balance. 
The absorption and retention values in the present study are very different from 
those reported by other researchers.  Ponies consuming 5.64-25.67 mg Cu/100 kg BW 
had fecal Cu excretion in the range of 2.88-14.18 mg Cu/100 kg BW while urinary 
excretion remained constant at 0.12 mg Cu/100 kg BW (Cymbaluk et al., 1981).  
Schryver et al. (1980) also reported low urinary excretion of Zn (0.7-1.0 mg Zn/100 kg 
BW) in ponies consuming 36.8-310.7 mg Zn/100 kg BW, with a subsequent fecal Zn 
excretion of 34.3-264.7 mg/100 kg BW.  Ponies consuming an average of 11.65 mg 
Cu/100 kg BW while fed increasing concentrations of Zn had an average fecal excretion 
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of 5.9 mg/100 kg BW and urinary excretion of 0.05 mg/100 kg BW (Hoyt et al., 1995).  
Urinary excretion of Zn for these ponies averaged 1.0 mg/100 kg BW despite increasing 
intakes of Zn ranging 76.6-606.8 mg/100 kg BW.   
Feed, fecal, urine and water analyses were performed by an outside laboratory, 
with blinded standard checks mixed in with the submitted samples.  Because the check 
standards analyzed within accepted values, it can be assumed that the laboratory results 
are accurate.  All samples were stored in mineral-free plastic containers and sealed to 
prevent outside contamination.  Feed samples tested at values similar to those obtained 
from diet calculations.  It is possible that fecal and urine samples may have been 
exposed to contaminants during the total collection process.  However, great care was 
taken by all workers to minimize risk of sample contamination.  As outlined in Chapter 
III, all collection equipment was checked and thoroughly cleaned throughout the 
collection phase.  This included frequent sweeping to remove dust, dander and hair.  If a 
fecal or urine sample became contaminated, it was not included the daily aliquot.  Given 
these procedures, it seems unlikely that a single sample could be contaminated.  A single 
contaminated sample would present itself as an outlier value during statistical analysis of 
the balance data.  However, all fecal and urine samples, and subsequent calculations of 
daily mineral excretion, resulted in consistently higher-than-expected values.  These 
results suggest either widespread sample contamination or some other event that caused 
the horses to excrete more mineral than was consumed.   
Work by Schryver et al. (1980) and Cymbaluk et al. (1981) used balance studies 
in conjunction with isotope work to determine the sources of endogenous mineral losses 
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of Zn and Cu, respectively.  Cymbaluk et al. (1981) constructed a regression analysis of 
Cu intake (x) and retention (y) generating the equation y = 0.66x – 3.47 (r=0.882).  The 
predicted obligatory Cu loss in mature ponies was 3.47 mg Cu/100 kg BW/d.  This 
prediction value was similar to the estimated obligatory Cu loss generated in work with 
bile duct-cannulated ponies in the same study.  Schryver et al. (1980) reported recovery 
of 83-88% of an intravenous dose of 65Zn in the feces of horses over a 14-d period.   A 
review of the literature did not reveal documentation of obligatory Zn loss in horses.  
Hoyt et al. (1995) fed ponies varying concentrations of Zn while holding Cu intake 
constant.  Using the approach of Cymbaluk et al. (1981) on the mean balance data 
reported by Hoyt et al. (1995), a basic regression of Zn retention (y) on intake (x) 
generated the equation y = 0.42x – 10.47 (r=.0.99), predicting an obligatory Zn loss of 
10.47 mg Zn/100 kg BW/d.  However, caution should be taken with this extrapolation as 
there is no validation of obligatory Zn loss through isotope work as was performed for 
Cu by Cymbaluk et al. (1981). 
Using the estimated obligatory losses of 3.47 mg Cu/100 kg BW and 10.47 mg 
Zn/100 kg BW/d, true absorption and retention in the present study were calculated 
(Tables 7 and 8, Appendices 3 and 4).  Adjusted fecal excretion of both Cu and Zn was 
different between the diets.  There was no difference in true absorption of either Cu or 
Zn by diet.  Copper absorbed as a percent of intake tended to be different by period 
(P=0.05) and had a diet by period interaction.  There was a trend for Cu retention as a 
percent of intake to be different by diet (P=0.09).  There were also trends for diet by 
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period interactions for true Zn absorption (P=0.06) and Zn retention (P=0.08).  No other 
significant differences or trends were noted. 
 
Table 7. True Daily Copper Absorption and Retention 
  Treatment 
  Sulfate Organic Chelate Total 
    Mean SEM Mean SEM Mean SEM 
Intake, mg/100kg BW 10.53* 0.62 35.73* 1.27 24.71 3.31 
Adjusted Fecal Excretion, mg/100kg BW 9.68* 0.66 35.12* 1.89 23.99 3.43 
True Absorption, mg/100kg BW 0.85 0.63 0.62 0.89 0.72 0.55 
 % of intake 7.46 6.10 2.11 2.46 4.45 2.97 
Urinary Excretion, mg/100kg BW 3.43 1.02 3.46 1.50 3.45 0.92 
Retained, mg/100kg BW -2.58 1.19 -2.85 1.61 -2.73 1.01 
 % of intake -24.34 10.77 -7.39 4.36 -14.80 5.54 
  % of absorbed -1960.38 1336.62 -1156.03 1156.38 -1507.93 851.13 
*Row means differ (P<0.05)       
  
Table 8. True Daily Zinc Absorption and Retention  
  Treatment 
  Sulfate Organic Chelate Total 
    Mean SEM Mean SEM Mean SEM 
Intake, mg/100kg BW 57.72* 2.02 136.48* 5.17 102.02 10.51 
AdjustedFecal Excretion, mg/100kg BW 61.67* 3.56 143.18* 5.38 107.52 10.95 
True Absorption, mg/100kg BW -3.96 4.54 -6.69 6.11 -5.50 3.86 
 % of intake -8.06 8.57 -5.87 5.01 -6.83 4.52 
Urinary Excretion, mg/100kg BW 3.53 0.77 3.69 0.52 3.62 0.43 
Retained, mg/100kg BW -7.49 4.81 -10.38 6.21 -9.11 3.97 
 % of intake -14.20 9.22 -8.58 5.10 -11.04 4.82 
  % of absorbed 225.64 107.46 56.86 51.58 130.71 57.33 
*Row means differ (P<0.05)       
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Plasma Mineral Concentrations 
 Changes in plasma Cu and Zn concentrations are illustrated in Figure 1.  Mean 
Cu concentrations varied from 0.66 to 0.89 ppm and Zn values ranged 0.37 to 0.53 ppm 
(Appendices 5 and 6).  These observed values, including those at the initiation of the 
study, are considerably lower than those reported by Ralston (1992) and the “normal” 
range for North American horses (Hintz, 1982). The present results are similar to the 
values obtained (0.81 ppm Cu and 0.52 ppm Zn) from horses in a known Cu and Zn 
deficient region (Górecka et al., 1999), as well as those observed in apparently normal 
horses in Australia (Auer et al., 1988).  Cymbaluk et al. (1986) reported plasma mineral 
concentration can vary by age and breed of horse.  Plasma Cu and Zn concentration may 
not be an adequate tool for comparing mineral status among separate research projects, 
but appears be a good tool for tracking mineral status within a given research project.   
Diet did not affect plasma Cu and Zn concentrations when horses were fed the 
experimental diets, nor was there a difference in normalized values between diets.  There 
was a trend (P=0.05) for plasma Cu concentration to increase while horses were on the 
experimental diets while Zn concentrations did not change.  There was no diet by day 
interaction observed in periods 4 and 7.  Initial plasma Zn concentrations were different 
between periods 4 and 7, but there was no difference in d 28 values or normalized values 
for the periods.     
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Figure 1. Plasma Mineral Concentration 
 
The repletion-depletion diet cycle used in this study was designed in response to 
questions about pre-study mineral balance in work by Wagner et al. (2005).  The 
purpose of the background and washout periods was to deplete body stores in an effort to 
standardize horses’ responses to the experimental diets.  This methodology proved to be 
effective for plasma Zn concentrations, which decreased from d 1 to d 29.  Prior to the 
study, horses were maintained on pasture and fed a commercially available concentrate.  
The observed change in plasma Zn during period 1 demonstrated that feeding the 
mineral deficient diet led to depletion of Zn stores.  Zinc concentrations remained 
unchanged from d 29 to d 85.  Plasma Cu concentrations did not change significantly 
from d 1 to d 85. 
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In order to validate the use of the washout periods, t-tests were used to compare 
plasma mineral concentrations during repeated phases of the background and washout 
period sequences.  Mean plasma Cu and Zn concentrations were not different between d 
57 and d 141, the conclusion of the repletion periods.  Plasma mineral concentrations 
were different at d 85 and d 169, the days representing the end of depletion periods and 
the start of feeding the experimental diets.   
Differences were observed in plasma mineral concentrations following the 
depletion diets (Table 9). Plasma Cu concentration was greater on d 169 than d 85.  Diet 
history did not influence this difference, as means were similar among horses coming off 
the background sequence and those previously subject to the sulfate and organic chelate 
diets in period 4.  Plasma Zn concentration was greater on d 85.  Diet history appeared to 
influence this observation (Table 9). Horses that just completed the background diet 
sequence in periods 1-3 had significantly greater plasma Zn concentrations than those 
fed the chelate diet during period 4.  There was no difference between horses coming off 
the background sequence and sulfate experimental diet, nor was there a difference 
between horses previously fed the sulfate or organic chelate experimental diets.   There 
was a numerical difference in the mineral concentration of the depletion diets fed in 
periods 3 and 6 (Table 1), though it is doubtful that such small variation could elicit the 
differences observed in plasma mineral concentrations between d 85 and 169.  
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Table 9.  Plasma Mineral Concentrations with 
Respect to Diet History 
 Day 85 Day 169
Prior Treatment 
Sequence Background 
Washout 
(Total) 
 Mean SEM Mean SEM 
Copper (ppm) 0.66 0.05 0.83 0.04 
Zinc (ppm) 0.48 0.02 0.37 0.01 
     
 Day 169
Prior Experimental Diet Sulfate 
Organic 
Chelate 
 Mean SEM Mean SEM 
Copper (ppm) 0.87 0.07 0.78 0.04 
Zinc (ppm) 0.39 0.01 0.35 0.01 
 
 
Ceruloplasmin Concentration 
Mean ceruloplasmin concentrations by period are illustrated in Figure 2.  There 
was no significant change in ceruloplasmin concentration as horses transitioned through 
the initial background diet sequence.  In comparing the repeated phases of the study, 
there was no difference in ceruloplasmin concentrations between d 57 and d 141, when 
horses completed the repletion diet periods.  This is similar to what was observed in 
plasma Cu concentrations during this time. 
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Figure 2. Mean Ceruloplasmin Concentration by Period 
 
In contrast to observed plasma Cu values, ceruloplasmin concentration was 
greater on d 85 than d 169.  Diet history appeared to influence this difference, as horses 
completing the background sequence had significantly greater ceruloplasmin 
concentrations than horses that were previously fed the sulfate supplemented 
experimental diet.  There was no difference between horses from the background phase 
and those fed the chelate diet, nor was there a difference between horses recently fed the 
sulfate or organic chelate experimental diets. 
Diet had no affect on ceruloplasmin concentrations when horses were fed the 
sulfate or organic chelate experimental diets, nor was there a period effect (Figure 3).  
There was a difference by day during periods 4 and 7, as ceruloplasmin increased from 
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Figure 3. Changes in Ceruloplasmin Concentration During  
Experimental Diet Periods 
  
25.84 mg/100mL to 39.57 mg/100mL d 1 to d 29 of the periods.  Ceruloplasmin 
concentrations were not different between d 1 and d 23 of the experimental periods, but 
increased significantly during the total collection.  This observation supports the role of 
ceruloplasmin as an acute-phase protein responsive to inflammation (Auer, 1989). 
 Ceruloplasmin assays used in equine research are not consistent in terms of 
conditions of the assay, oxidizing reagent used and unit of measurement, making it 
difficult to directly compare reported values.  Values in the present study are similar to 
those reported in donkeys (Bingley and Dick, 1969).  Ceruloplasmin activity was 
reduced in horses consuming 5.64 mg Cu/100 kg BW/d compared to those with a Cu 
intake of 16.60 mg/100 kg BW (Cymbaluk et al., 1981).  In that study, the difference in 
ceruloplasmin activity mirrored the difference in plasma Cu concentration between the 
diets.  That type of relationship was not as apparent in the present study.  Ceruloplasmin 
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is a better indicator of Cu deficiency rather than adequacy (Harris, 2006), but little has 
been reported regarding ceruloplasmin response to exercise as seen in the present study.  
The novel interaction of exercise stress and marginally deficient diets may have resulted 
in ceruloplasmin responses unexplained by previous research.   
 
Standard Exercise Test 
One horse was not able to complete the second SET due to psychological and 
safety concerns, and the test was halted during the first cantering bout.  Heart rate data 
collected prior to the cessation of the test was included in the statistical analyses.  All 
other horses completed tests without incident. The observed heart rates were considered 
normal for this intensity of work.   
Seven of the nine horses completed the first SET on the treadmill.  Mechanical 
failure necessitated the use of the mechanical walker for the remaining SETs.  Horses 
were subject to the same speeds and distances on both machines.  There was no 
difference in heart rates between diets.  Mean heart rates during the SET were greater 
during period 4 (Figure 4, Appendix 7).  Statistical analysis could not determine if the 
difference was a period effect or a machine effect.  Horses spent the first two periods of 
the research project in a conditioning program, and were performing the prescribed 
exercise regimen for the eight weeks leading up to the first SET.  It is possible that the 
horses became more fit in the 12 weeks between SETs.  The treadmill was set at an 
angle that should have created approximately the same workload as horses working over 
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Figure 4. Standard Exercise Test Heart Rates 
 
the ground (Barrey et al., 1993; Courouce et al., 2000), though the angle could have 
caused horses to work harder than during over-ground work.  Horses had several training 
sessions on the treadmill in the weeks leading up to the SET, so it is unlikely that the 
novelty of working on the treadmill caused the observed difference in heart rates.   
 
Erythrocyte Superoxide Dismutase 
 There was no change in SOD activity from d 1 to d 23 of periods 4 and 7, nor 
was there a diet or period effect for SOD activity at rest on d 23 (Table 10).  These 
values are similar to those reported by Gόrecka et al. (1999) who noted activity of 
1752.03 ± 363.16 U/g Hb in horses assumed to be Cu and Zn deficient whereas horses 
presumed to be mineral adequate had a mean value of 1118.20 ± 430.15 U/g Hb.  In that 
study, the group of horses assumed to be mineral deficient had plasma mineral  
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Table 10. Erythrocyte Superoxide Dismutase Activity 
 Period 4 Period 7   
 Mean SEM Mean SEM  
Day 1 1614.53 192.58 1761.29 241.16  
Day 23 1596.89 223.03 1504.64 300.95  
 
concentrations of 0.81 ppm Cu and 0.52 ppm Zn which was greater than the d 85 Cu 
concentration and both d 85 and d 169 Zn values in the present study.   
Polish researchers reported an increase in SOD activity in horses from a Cu and 
Zn deficient geographical region, suggesting a compensatory effect for decreased plasma 
mineral and ceruloplasmin concentrations (Górecka et al., 1999). Horses in the present 
study were on a Cu and Zn deficient diet prior to the first SOD sampling, and were either 
on a marginally deficient diet (sulfate supplementation) or a Cu and Zn sufficient diet 
(organic chelate supplementation) during periods 4 and 7.  While this study did not 
reveal differences in erythrocyte SOD activity due to mineral intake status, it does not 
rule out possible effects from long term (i.e. more than 28 d) mineral deficiency.   
Superoxide dismutase activity did not change over the course of the SET (Figure 
5, Appendix 8).  The Randox kit procedure uses hemoglobin concentrations to correct 
for changes in red blood cell count, an important consideration in horses where a splenic 
contraction increases circulating red blood cells in response to exercise.  The observed 
lack of SOD response to this exercise test is in agreement with observations during short 
term, high intensity treadmill work (Ji et al., 2001) as well as observations before and 
after a pentathlon competition (Balogh et al., 2001).   
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Immune Function 
 Mean total WBC was not different by diet, nor was there a diet by day 
interaction.  There was a significant difference by day, where the mean d 1 and d 28 
counts were greater than d 23, though d 1 and d 28 were not different from each other 
(Figure 6).  White blood cell counts were higher for horses in period 4, though there was 
no difference in d 1 values between periods (Figure 7).    
Diet did not influence absolute lymphocyte count (Figure 8), however there as a 
trend (P=0.07) for a difference by day as the lymphocyte count decreased from d1 to d 
23.  There was no diet by day interaction or period effect.   
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Figure 6. Total White Blood Cell Count by Day 
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Figure 7. Total White Blood Cell Count by Period 
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Figure 8. Lymphocyte Count 
 
Differential cell counts indicated the percent of the total WBC constituted by 
neutrophils, lymphocytes, monocytes, eosinophils and basophils.  Figures 9-14 illustrate 
the differential cell counts.  There was no difference by diet, day, diet by day interaction 
or period for differential neutrophils, lymphocytes, eosinophils and basophils.  
Differential monocyte counts were different by day from d 1 to d 28 of the experimental 
periods, but there was no difference by diet, diet by day interaction or period. 
The increase in WBC during the total collection period, d 23 to d 28, may 
indicate an immune challenge presented to the horses due to the stress of the collection.  
The lack of change in differential counts over the course of the total collection suggests 
that both acquired and innate immune functions were summoned in this response.  
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Lymphocytes are part of the adaptive immunity response whereas the other white cells 
are associated with some type of innate response (Abbas and Lichtman, 2005).   
Means tables for all white blood cell data are found in Appendices 9 and 10.   
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Figure 9. Differential Neutrophil Count 
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Figure 10. Differential Lymphocyte Count 
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Figure 11. Differential Eosinophil Count 
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Figure 12. Differential Basophil Count 
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Figure 13. Differential Monocyte Count 
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Figure 14. Mean Differential Monocyte Count by Day 
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The lack of difference in total WBC by diet is in agreement with work using 
receiving steers (Kegley et al., 2001).  While the present study did not use measures of 
acquired immunity such as antibody titers and immunoglobulin (Ig) counts, studies using 
those indices of immune function usually saw no difference by diet (Ahola et al., 2005a; 
Ahola et al., 2005b; Kegley et al., 2001).  These indices were not possible in the present 
study as the switchback design would have created a carryover effect.  A longer study, or 
one using completely separate groups of animals for the treatments, would be a better 
opportunity to examine antibody titers to vaccines for respiratory illness or even 
challenge horses with some type of antigen.  While in vitro analyses, such as pokeweed 
mitogen and phytohemagglutinin challenge assays, have been used in supplementation 
studies in cattle (Kincaid et al., 1997; Spears and Kegley, 2002), they may not be the 
most effective tools for examining immune function in this context (Tizzard, 2005).   
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CHAPTER V 
GENERAL DISCUSSION 
 
Research in various species of livestock has examined differences in 
performance or body function when animals were fed mineral supplements of different 
chemical compositions.  Results have been mixed, finding organic-chelates to be 
comparable to or better than sulfate or oxide supplement formulations.  In horses, 
concerns regarding copper and zinc function in skeletal development and other 
physiological processes drive the need to define a superior supplementation form.  As 
the horse industry becomes a target for environmental regulations already seen in other 
production livestock industries, trace mineral nutrition will take on another challenge in 
improving the efficiency of supplementation.   
Previous research from this laboratory (Wagner et al., 2005) compared the 
absorption and retention of copper and zinc in mature, idle horses, concluding that there 
were no differences in absorption among sulfate, oxide and organic-chelate forms of 
supplementation for horses in this metabolic state.  It was postulated that horses in a 
state of increased mineral demand, such as intense exercise, may be a more ideal model 
for comparing forms of trace mineral supplementation.   
From this work, the present study was designed, keeping in mind the objectives 
of comparing absorption and retention of Cu and Zn in exercising horses as well as to 
document physiologic changes in select Cu and Zn dependent systems.  To this end, 
plasma mineral concentrations and ceruloplasmin concentration were tracked throughout 
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the study, and SOD activity and immune function were examined during periods where 
horses consumed Cu and Zn from sulfate or organic-chelate sources.   
A formulation error resulted in horses on the organic-chelate diet consuming 
about three times the amount of Cu and Zn of that provided in the sulfate supplemented 
diet.  Fecal mineral excretion for the groups reflected this disparity in mineral intake.   
Horses also had negative absorption of Cu and Zn when consuming the experimental 
diets, including those consuming Cu and Zn concentrations well above NRC (1989) 
requirements.  Mineral deficiency, as characterized by negative absorption, was also 
unlikely as horses were also excreting Cu and Zn in the urine.  There was a significant 
difference in apparent absorption of Cu as a percent of intake as well as retention of Cu 
as a percent of intake between the sulfate and organic-chelate supplemented diets.  There 
was no difference in apparent retention or retention as a percent of absorption for Cu.  
No significant differences were noted for absorption as a percent of intake, retention, 
retention as a percent of intake and retention as a percent of mineral absorbed for Zn. 
When Cu and Zn absorption was corrected for endogenous fecal mineral losses, 
true absorption values remained lower than those reported in other balance studies.  
Great care was taken in the feeding and management of horses to prevent mineral intake 
from undocumented sources, and sample collection and processing was carried out using 
practices designed to minimize sample contamination.   The most plausible explanation 
for the values reported would be fecal and urine sample contamination, though the 
source of contamination cannot be determined at this time.  It is also possible that the 
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depletion diet periods were not sufficient in reducing body mineral stores to a deficient 
status.   
The research project was designed to subject horses to periods of controlled 
depletion and repletion of mineral stores.  There was a significant decrease in plasma Zn 
concentration as horses were removed from their commercially available concentrate 
and fed a basal diet with no supplemental Cu and Zn.  Plasma Cu and Zn decreased 
numerically, but not significantly, through the first 85-d of the project which served as a 
background period.  In the 56-d washout period between periods 4 and 7, horses were 
again fed a repletion-depletion diet sequence.  While there was no difference in plasma 
mineral concentrations between d 56 and d 141, there was a difference in d 85 and d 169 
values, the days preceding the experimental diet periods.  Despite a significant 
difference in mineral intake during periods 4 and 7, plasma mineral concentrations were 
not different between treatment groups. 
As a Cu-dependent protein, ceruloplasmin changes reflected the mineral intake of 
horses during the research project.  As was observed with plasma mineral 
concentrations, there was no difference by diet on ceruloplasmin concentration in 
periods 4 and 7.  In contrast to the difference in plasma Cu concentrations between d 85 
and d 169, ceruloplasmin concentrations were actually lower on d 169.  During period 4 
and 7, ceruloplasmin concentrations increased significantly during the total collection 
period.  This change was most likely a response to the physical stress of standing in tie 
stalls for the collection period, as ceruloplasmin has been identified as acute-phase 
protein for inflammation.   
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There was a difference in heart rate response to the exercise tests performed in 
periods 4 and 7, though it could not be determined if it was a period or machine effect.  
Source of mineral supplementation did not have an effect on heart rate.  Superoxide 
dismutase activity did not change over the course of the exercise test.  There was no 
difference in resting SOD activity between d 1 and d 23 of the experimental diet periods, 
nor was SOD activity influence by mineral source.   
Immune function as measured by total white blood cell count, lymphocyte count 
and differential white blood cell count was not different by diet treatment in periods 4 
and 7.  While total WBC was similar on d 85 and d 169, there was a period effect. 
Studies in cattle reported similar findings regarding WBC in response to supplement 
form.  Antibody titers may be a more effective test for comparing immune response, but 
the present project design did not allow for this type of analysis. 
There continues to be a need to define the advantage, if any, of preferably 
feeding one mineral supplement form over another.  The present study was designed to 
examine this issue, but formulation and sample contamination issues complicated a 
comparison of mineral balance data.  Copper provided in the organic-chelate supplement 
was more available when considering apparent absorption as a percent of intake and 
retention as a percent of intake.  However there was no difference in apparent Zn 
absorption as a percent of intake, nor was there no significant difference between the 
sulfate and organic chelate forms of Cu and Zn when comparing true absorption.  Based 
on changes in plasma mineral concentrations, the use of a repletion-depletion diet 
sequence appears to be effective in depleting and standardizing body mineral stores.  
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While liver biopsies are considered a risky procedure in horses, it may be interesting to 
see how liver mineral stores compare to these observed changes in plasma mineral 
concentrations in animals subject to a similar diet treatment sequence.  Ceruloplasmin 
concentrations can also serve as an indicator of a Cu deficient state, but its function as an 
acute-phase protein has the potential to confound results if horses are subject to 
inflammation-inducing events.  Based on results from the present study, Cu,Zn-SOD and 
WBC are not responsive to changes in diet Cu and Zn concentration over a 23 d period. 
The confounding circumstances of the experimental diet periods in the present 
study made it difficult to assess the use of the mature, exercising horse as a model for 
mineral balance studies.  Moderate to intense exercise does place stress on body systems, 
though more intense exercise may be more effective in evaluating mineral balance.  
Mineral balance in the mature equine athlete should be re-evaluated before looking at the 
more complicated model of the juvenile athlete, where growth and exercise stress can 
influence Cu and Zn demand.    
Regardless of age or use of animal, future balance studies must also consider 
mineral absorption efficiency in terms of environmental impact.  Mineral consumption 
in excess of body needs will result in more mineral excreted from the horse.  As small 
and large scale equine facilities struggle with waste management and removal, nutrient 
disposal concerns will become a bigger issue in the equine industry. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
 The present study was designed to compare absorption and retention of Cu and 
Zn in exercising horses when supplemented in either the sulfate or organic-chelate form.  
To accomplish this, nine horses were subject to a modified switchback designed 
experiment consisting of seven 28-d periods.  A controlled repletion-depletion diet 
sequence was fed prior to consumption of an experimental diet in periods 4 and 7, where 
Cu and Zn were supplemented at 90% of NRC (1989) values using sulfate or specific 
amino acid chelate supplements.  Horses were conditioned to perform an average daily 
workload of 3.93 kg*km*10-3, creating a DE demand of 28.8 Mcal.  Blood samples were 
drawn at regular intervals for analysis of plasma Cu, Zn and ceruloplasmin 
concentrations.  White blood cell counts and SOD activity were assayed during periods 4 
and 7.  Horses were subjected to a standard exercise test on d 23 of periods 4 and 7 for 
the purpose of measuring SOD activity during exercise.  A 4-d total collection beginning 
d 24 of periods 4 and 7 was used to assess Cu and Zn balance.   
 Dietary copper and zinc intakes were different between supplement forms in 
periods 4 and 7 due to a formulation error.  This resulted in horses on the organic-chelate 
supplemented diet consuming nearly three times the amount of mineral as those on the 
sulfate supplemented diet.  Apparent and true absorption of Cu and Zn were different by 
diet.  Absorption as a percent of intake and retention as a percent of intake were 
negative, suggesting the possibility of sample contamination.  Copper-lysine was more 
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available than CuSO4 when measured as apparent absorption as a percent of intake, but 
there were no differences in apparent Zn or true Cu and Zn absorption as a percent of 
intake.  Plasma Cu, Zn and ceruloplasmin concentrations, as well as immune function 
and SOD activity were not influenced by diet in periods 4 and 7.  Plasma Cu, Zn and 
ceruloplasmin concentrations fluctuated throughout the experiment, and there was a 
significant difference in all three when comparing d 85 and d 169.  Ceruloplasmin 
concentration increased significantly during the total collection period.  Erythrocyte 
Cu,Zn-SOD activity remained consistent throughout the exercise test.   
 Conclusions regarding availability of Cu and Zn provided in the sulfate or 
organic-chelate forms are mixed.  The use of a repletion-depletion diet sequence 
appeared to be somewhat effective in standardizing individual mineral status in adult 
horses, however 28-d periods may not be long enough to deplete body stores.  
Superoxide dismutase and WBC did not respond to changes in diet in the present study, 
and may not be suitable measures for similar project designs.  The mature, exercising 
horse still appears to be an appropriate model for mineral balance studies.  Further 
investigation is needed to generate data suitable for evaluating differences in Cu and Zn 
absorption, retention and availability in the horse. 
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APPENDIX 1. COPPER BALANCE 
                       
Horse Period Diet 
Body 
Weight 
kg 
Conc. 
Intake 
DM 
kg/d 
Conc. 
Cu 
mg/kg 
Conc. 
Cu 
mg/d 
Hay 
Intake 
DM 
kg/d 
Hay Cu 
mg/kg 
Hay Cu 
Intake 
mg/d 
Total 
Feed 
Cu 
mg/d 
Water 
Intake 
L/d 
1A 4 sulfate 429.11 3.18 7.00 22.27 3.22 4.60 14.80 37.07 14.07
2A 4 sulfate 514.39 4.30 7.00 30.13 4.34 4.60 19.97 50.09 23.29
3A 4 sulfate 530.26 3.58 7.00 25.07 3.62 4.60 16.65 41.72 36.76
5A 4 sulfate 494.42 4.16 10.00 41.56 4.15 5.30 21.99 63.55 22.16
1B 4 chelate 429.56 2.53 41.00 103.76 2.91 4.60 13.41 117.17 14.98
2B 4 chelate 533.44 4.61 41.00 189.15 4.68 4.60 21.51 210.66 23.68
3B 4 chelate 546.13 4.28 41.00 175.59 4.20 4.60 19.33 194.93 20.49
4B 4 chelate 514.39 4.10 41.00 168.17 4.14 4.60 19.03 187.20 22.27
5B 4 chelate 516.65 3.63 42.00 152.46 3.68 5.30 19.51 171.98 15.46
1A 7 chelate 458.13 3.15 45.00 141.86 3.22 3.50 11.27 153.13 15.21
2A 7 chelate 527.54 4.29 45.00 192.99 4.35 3.50 15.24 208.23 20.63
3A 7 chelate 519.37 3.57 45.00 160.58 3.63 3.50 12.69 173.27 29.33
5A 7 chelate 530.71 4.00 46.00 183.87 3.92 3.90 15.27 199.15 32.71
1B 7 sulfate 400.98 2.05 9.00 18.44 2.61 3.50 9.13 27.57 8.96
2B 7 sulfate 544.32 4.75 9.00 42.79 4.70 3.50 16.46 59.26 19.06
4B 7 sulfate 522.55 4.23 9.00 38.05 4.08 3.50 14.27 52.32 21.19
5B 7 sulfate 534.34 3.66 9.00 32.96 3.62 3.90 14.10 47.06 20.65
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APPENDIX 1. CONTINUED 
                       
Water 
Cu 
Intake 
mg/d 
Total 
Cu 
Intake 
mg/d 
Water 
Cu 
mg/L 
Cu Intake 
mg/100kg 
BW 
Conc. 
Cu 
mg/L 
Urine 
Cu 
mg/d 
Urine Cu 
mg/100kg 
BW 
Fecal 
DM 
kg/d 
Urine 
L/d Horse Period Diet 
1A 4 sulfate 0.20 2.87 39.94 9.31 4.42 0.83 3.66 0.85 2.26
2A 4 sulfate 0.20 4.75 54.84 10.66 8.08 2.55 20.58 4.00 3.78
3A 4 sulfate 0.20 7.50 49.22 9.28 17.50 1.34 23.39 4.41 2.98
5A 4 sulfate 0.17 3.85 67.41 13.63 9.62 1.70 16.38 3.31 3.18
1B 4 chelate 0.20 3.06 120.23 27.99 3.80 1.16 4.40 1.02 2.10
2B 4 chelate 0.20 4.83 215.49 40.40 7.97 1.15 9.14 1.71 3.98
3B 4 chelate 0.20 4.18 199.11 36.46 5.36 4.18 22.37 4.10 3.22
4B 4 chelate 0.20 4.54 191.75 37.28 8.63 1.17 10.11 1.97 2.92
5B 4 chelate 0.17 2.69 174.67 33.81 7.45 1.70 12.69 2.46 3.36
1A 7 chelate 0.14 2.19 155.32 33.90 4.65 1.20 5.57 1.22 2.24
2A 7 chelate 0.14 2.97 211.20 40.03 5.71 1.09 6.21 1.18 3.74
3A 7 chelate 0.14 4.22 177.49 34.17 16.32 0.75 12.25 2.36 2.81
5A 7 chelate 0.01 0.16 199.31 37.56 14.77 5.45 80.48 15.17 3.03
1B 7 sulfate 0.14 1.29 28.86 7.20 5.10 6.73 34.32 8.56 1.61
2B 7 sulfate 0.14 2.74 62.00 11.39 6.91 6.79 46.90 8.62 3.65
4B 7 sulfate 0.14 3.05 55.37 10.60 7.86 1.24 9.71 1.86 3.13
5B 7 sulfate 0.01 0.10 47.16 8.83 7.06 0.73 5.11 0.96 3.07
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APPENDIX 1. CONTINUED 
                        
Cu 
Absorbed 
mg/100kg 
BW 
Cu 
Retained 
mg/100kg 
BW 
Fecal 
Cu 
mg/kg 
Fecal 
Cu 
mg/d 
Fecal Cu 
mg/100kg 
BW 
Cu Abs. 
% 
Intake 
Cu Ret. 
%  
Intake 
% 
Digestible 
DM 
Cu Ret. 
% Abs. Horse Period Diet 
1A 4 sulfate 19.97 45.13 10.52 -1.21 -13.00 -2.06 -22.17 170.58 64.68
2A 4 sulfate 19.08 72.13 14.02 -3.36 -31.51 -7.36 -69.03 219.09 56.27
3A 4 sulfate 19.13 56.99 10.75 -1.47 -15.79 -5.88 -63.31 401.04 58.63
5A 4 sulfate 21.85 69.46 14.05 -0.42 -3.05 -3.73 -27.36 896.98 61.72
1B 4 chelate 59.10 124.35 28.95 -0.96 -3.43 -1.98 -7.09 206.76 61.36
2B 4 chelate 63.70 253.71 47.56 -7.16 -17.73 -8.88 -21.98 123.92 57.13
3B 4 chelate 67.70 217.84 39.89 -3.43 -9.41 -7.53 -20.64 219.38 62.08
4B 4 chelate 65.20 190.33 37.00 0.28 0.74 -1.69 -4.54 -614.07 64.57
5B 4 chelate 60.00 201.61 39.02 -5.22 -15.43 -7.67 -22.69 147.09 54.04
1A 7 chelate 69.00 154.65 33.76 0.15 0.43 -1.07 -3.16 -736.15 64.83
2A 7 chelate 64.40 240.96 45.68 -5.64 -14.09 -6.82 -17.03 120.86 56.70
3A 7 chelate 67.40 189.30 36.45 -2.27 -6.65 -4.63 -13.55 203.81 60.96
5A 7 chelate 68.20 206.85 38.98 -1.42 -3.78 -16.59 -44.16 1167.09 61.67
1B 7 sulfate 18.51 29.80 7.43 -0.23 -3.26 -8.79 -122.19 3748.05 65.44
2B 7 sulfate 22.00 80.40 14.77 -3.38 -29.67 -12.00 -105.32 354.97 61.36
4B 7 sulfate 23.16 72.50 13.87 -3.28 -30.94 -5.14 -48.47 156.68 62.31
5B 7 sulfate 24.46 75.01 14.04 -5.21 -59.05 -6.17 -69.89 118.37 57.86
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APPENDIX 2. ZINC BALANCE 
                        
Conc. 
Intake 
DM 
kg/d 
Hay 
Intake 
DM 
kg/d 
Body 
Weight 
kg 
Conc. 
Zn 
mg/kg 
Hay Zn 
Intake 
mg/d 
Total 
Feed 
Zn mg/d 
Water 
Intake 
L/d 
Conc. 
Zn mg/d 
Hay Zn 
mg/kg Horse Period Diet 
1A 4 sulfate 429.11 3.18 47.00 149.56 3.22 26.20 84.28 233.84 14.07
2A 4 sulfate 514.39 4.30 47.00 202.27 4.34 26.20 113.73 316.00 23.29
3A 4 sulfate 530.26 3.58 47.00 168.30 3.62 26.20 94.84 263.14 36.76
5A 4 sulfate 494.42 4.16 48.00 199.50 4.15 20.20 83.81 283.31 22.16
1B 4 chelate 429.56 2.53 148.00 374.56 2.91 26.20 76.36 450.92 14.98
2B 4 chelate 533.44 4.61 148.00 682.79 4.68 26.20 122.53 805.32 23.68
3B 4 chelate 546.13 4.28 148.00 633.85 4.20 26.20 110.11 743.96 20.49
4B 4 chelate 514.39 4.10 148.00 607.06 4.14 26.20 108.40 715.46 22.27
5B 4 chelate 516.65 3.63 153.00 555.40 3.68 20.20 74.37 629.77 15.46
1A 7 chelate 458.13 3.15 164.00 516.98 3.22 24.10 77.61 594.60 15.21
2A 7 chelate 527.54 4.29 164.00 703.34 4.35 24.10 104.91 808.26 20.63
3A 7 chelate 519.37 3.57 164.00 585.21 3.63 24.10 87.40 672.61 29.33
5A 7 chelate 530.71 4.00 174.00 695.52 3.92 23.80 93.21 788.73 32.71
1B 7 sulfate 400.98 2.05 48.00 98.33 2.61 24.10 62.89 161.22 8.96
2B 7 sulfate 544.32 4.75 48.00 228.23 4.70 24.10 113.35 341.58 19.06
4B 7 sulfate 522.55 4.23 48.00 202.92 4.08 24.10 98.27 301.18 21.19
5B 7 sulfate 534.34 3.66 48.00 175.77 3.62 23.80 86.06 261.83 20.65
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APPENDIX 2. CONTINUED 
                        
Water 
Zn 
Intake 
mg/d 
Total Zn 
Intake 
mg/d 
Zn Intake 
mg/100kg 
BW 
Urine Zn 
mg/100kg 
BW 
Fecal 
DM 
kg/d 
Water 
Zn mg/L 
Urine 
L/d 
Conc. 
Zn mg/L 
Urine 
Zn mg/d Horse Period Diet 
1A 4 sulfate 0.44 6.22 240.05 55.94 4.42 1.71 7.55 1.76 2.26
2A 4 sulfate 0.44 10.29 326.30 63.43 8.08 3.77 30.46 5.92 3.78
3A 4 sulfate 0.44 16.25 279.39 52.69 17.50 1.93 33.77 6.37 2.98
5A 4 sulfate 0.41 9.02 292.32 59.12 9.62 2.39 22.98 4.65 3.18
1B 4 chelate 0.44 6.62 457.54 106.51 3.80 2.53 9.60 2.24 2.10
2B 4 chelate 0.44 10.47 815.78 152.93 7.97 2.64 21.04 3.94 3.98
3B 4 chelate 0.44 9.05 753.02 137.88 5.36 7.43 39.79 7.29 3.22
4B 4 chelate 0.44 9.84 725.30 141.00 8.63 2.44 21.06 4.09 2.92
5B 4 chelate 0.41 6.29 636.06 123.11 7.45 2.51 18.70 3.62 3.36
1A 7 chelate 0.37 5.66 600.25 131.02 4.65 2.48 11.52 2.51 2.24
2A 7 chelate 0.37 7.68 815.93 154.67 5.71 2.14 12.21 2.31 3.74
3A 7 chelate 0.37 10.91 683.52 131.61 16.32 1.35 22.03 4.24 2.81
5A 7 chelate 0.16 5.33 794.06 149.62 14.77 1.05 15.51 2.92 3.03
1B 7 sulfate 0.37 3.33 164.55 41.04 5.10 1.56 7.96 1.98 1.61
2B 7 sulfate 0.37 7.09 348.68 64.06 6.91 1.54 10.64 1.95 3.65
4B 7 sulfate 0.37 7.88 309.07 59.15 7.86 1.36 10.68 2.04 3.13
5B 7 sulfate 0.16 3.37 265.20 49.63 7.06 1.52 10.72 2.01 3.07
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Fecal 
Zn 
mg/kg 
Fecal Zn 
mg/100kg 
BW 
Zn Abs. 
% 
Intake 
Zn Ret. 
%  
Intake 
% 
Digestible 
DM 
Fecal 
Zn mg/d 
Zn 
Absorbed
Zn 
Retained
Zn Ret. 
% Abs. Horse Period Diet 
1A 4 sulfate 105.70 238.88 55.67 0.27 0.49 -1.49 -2.66 -545.42 64.68
2A 4 sulfate 92.40 349.29 67.90 -4.47 -7.05 -10.39 -16.38 232.49 56.27
3A 4 sulfate 153.80 458.16 86.40 -33.71 -63.99 -40.08 -76.07 118.89 58.63
5A 4 sulfate 109.20 347.15 70.21 -11.09 -18.76 -15.74 -26.62 141.91 61.72
1B 4 chelate 310.70 653.73 152.19 -45.67 -42.88 -47.91 -44.98 104.89 61.36
2B 4 chelate 244.00 971.83 182.18 -29.25 -19.13 -33.20 -21.71 113.48 57.13
3B 4 chelate 275.10 885.21 162.09 -24.21 -17.55 -31.49 -22.84 130.10 62.08
4B 4 chelate 254.80 743.80 144.60 -3.60 -2.55 -7.69 -5.45 213.79 64.57
5B 4 chelate 244.50 821.56 159.02 -35.90 -29.16 -39.52 -32.10 110.08 54.04
1A 7 chelate 254.20 569.74 124.36 6.66 5.08 4.15 3.16 62.25 64.83
2A 7 chelate 232.10 868.42 164.62 -9.95 -6.43 -12.26 -7.93 123.26 56.70
3A 7 chelate 277.20 778.53 149.90 -18.29 -13.90 -22.53 -17.12 123.18 60.96
5A 7 chelate 251.80 763.72 143.90 5.72 3.82 2.80 1.87 48.90 61.67
1B 7 sulfate 99.70 160.52 40.03 1.01 2.45 -0.98 -2.38 -97.12 65.44
2B 7 sulfate 113.50 414.77 76.20 -12.14 -18.96 -14.10 -22.01 116.10 61.36
4B 7 sulfate 120.10 375.96 71.95 -12.80 -21.64 -14.85 -25.10 115.97 62.31
5B 7 sulfate 133.60 409.71 76.68 -27.05 -54.49 -29.05 -58.54 107.42 57.86
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APPENDIX 3. TRUE COPPER ABSORPTION 
                          
Cu 
Intake 
mg/100 
kg BW 
Urine 
Cu 
mg/100 
kg BW 
Fecal 
Cu 
mg/100 
kg BW 
Endog. 
Cu 
mg/100 
kg BW 
Adj. 
Fecal 
Cu 
True 
Cu 
Abs. 
True 
Cu Abs 
% Int 
True 
Cu Ret 
% Int 
True 
Cu Ret 
True Cu 
Ret % Abs Horse Period Diet 
1A 4 sulfate 9.31 0.85 10.52 3.47 7.05 2.26 24.28 1.41 15.11 62.22
2A 4 sulfate 10.66 4.00 14.02 3.47 10.55 0.11 1.04 -3.89 -36.49 -3523.07
3A 4 sulfate 9.28 4.41 10.75 3.47 7.28 2.00 21.60 -2.41 -25.93 -120.04
5A 4 sulfate 13.63 3.31 14.05 3.47 10.58 3.05 22.40 -0.26 -1.90 -8.50
1B 4 chelate 27.99 1.02 28.95 3.47 25.48 2.51 8.97 1.49 5.31 59.17
2B 4 chelate 40.40 1.71 47.56 3.47 44.09 -3.69 -9.14 -5.41 -13.39 146.39
3B 4 chelate 36.46 4.10 39.89 3.47 36.42 0.04 0.11 -4.06 -11.13 -10381.42
4B 4 chelate 37.28 1.97 37.00 3.47 33.53 3.75 10.05 1.78 4.77 47.50
5B 4 chelate 33.81 2.46 39.02 3.47 35.55 -1.75 -5.16 -4.20 -12.43 240.70
1A 7 chelate 33.90 1.22 33.76 3.47 30.29 3.62 10.66 2.40 7.08 66.35
2A 7 chelate 40.03 1.18 45.68 3.47 42.21 -2.17 -5.42 -3.35 -8.36 154.19
3A 7 chelate 34.17 2.36 36.45 3.47 32.98 1.20 3.50 -1.16 -3.40 -97.00
5A 7 chelate 37.56 15.17 38.98 3.47 35.51 2.05 5.46 -13.12 -34.93 -640.18
1B 7 sulfate 7.20 8.56 7.43 3.47 3.96 3.24 44.95 -5.32 -73.98 -164.57
2B 7 sulfate 11.39 8.62 14.77 3.47 11.30 0.09 0.79 -8.53 -74.85 -9419.56
4B 7 sulfate 10.60 1.86 13.87 3.47 10.40 0.19 1.81 -1.67 -15.72 -868.67
5B 7 sulfate 8.83 0.96 14.04 3.47 10.57 -1.74 -19.73 -2.70 -30.58 154.96
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APPENDIX 4. TRUE ZINC ABSORPTION 
                          
Horse Period Diet 
Zn 
Intake 
mg/100 
kg BW 
Urine 
Zn 
mg/100 
kg BW 
Fecal 
Zn 
mg/100 
kg BW 
Endog. 
Zn 
mg/100 
kg BW 
Adj. 
Fecal 
Zn 
True Zn 
Abs. 
True Zn 
Abs % 
Int 
True Zn 
Ret 
True Zn 
Ret % 
Int 
True Zn 
Ret % 
Abs 
1A 4 sulfate 55.94 1.76 55.67 10.47 45.20 10.74 19.20 8.98 16.06 83.62
2A 4 sulfate 63.43 5.92 67.90 10.47 57.43 6.00 9.46 0.08 0.12 1.31
3A 4 sulfate 52.69 6.37 86.40 10.47 75.93 -23.24 -44.11 -29.61 -56.20 127.40
5A 4 sulfate 59.12 4.65 70.21 10.47 59.74 -0.62 -1.05 -5.27 -8.91 850.49
1B 4 chelate 106.51 2.24 152.19 10.47 141.72 -35.20 -33.05 -37.44 -35.15 106.35
2B 4 chelate 152.93 3.94 182.18 10.47 171.71 -18.78 -12.28 -22.73 -14.86 121.00
3B 4 chelate 137.88 7.29 162.09 10.47 151.62 -13.74 -9.96 -21.02 -15.25 153.04
4B 4 chelate 141.00 4.09 144.60 10.47 134.13 6.87 4.87 2.78 1.97 40.43
5B 4 chelate 123.11 3.62 159.02 10.47 148.55 -25.43 -20.66 -29.05 -23.60 114.23
1A 7 chelate 131.02 2.51 124.36 10.47 113.89 17.13 13.07 14.62 11.16 85.32
2A 7 chelate 154.67 2.31 164.62 10.47 154.15 0.52 0.34 -1.79 -1.16 -344.76
3A 7 chelate 131.61 4.24 149.90 10.47 139.43 -7.82 -5.94 -12.06 -9.17 154.21
5A 7 chelate 149.62 2.92 143.90 10.47 133.43 16.19 10.82 13.27 8.87 81.95
1B 7 sulfate 41.04 1.98 40.03 10.47 29.56 11.48 27.97 9.49 23.13 82.71
2B 7 sulfate 64.06 1.95 76.20 10.47 65.73 -1.67 -2.61 -3.63 -5.66 216.88
4B 7 sulfate 59.15 2.04 71.95 10.47 61.48 -2.33 -3.94 -4.38 -7.40 187.70
112.11-37.44-18.58-16.58 -33.4066.2110.4776.682.015B 7 sulfate 49.63
 
APPENDIX 5. MEAN PLASMA COPPER, ZINC AND CERULOPLASMIN 
CONCENTRATION BY DAY 
          
  Copper  Zinc  Ceruloplasmin 
Day Mean SEM  Mean SEM  Mean  SEM 
1  0.89 0.05  0.53 0.05  30.03 1.71 
29  0.80 0.07  0.37 0.02  21.80 2.61 
57  0.73 0.07  0.44 0.02  26.02 3.62 
85  0.66 0.06  0.48 0.02  29.14 1.76 
108  - -  - -  32.46 5.58 
113  0.83 0.08  0.44 0.02  39.62 3.59 
141  0.78 0.04  0.42 0.02  31.05 2.17 
169  0.83 0.04  0.37 0.01  22.12 1.74 
192  - -  - -  25.89 4.41 
197   0.88 0.04  0.45 0.03  39.51 2.22 
 
 
 
APPENDIX 6. PLASMA COPPER AND ZINC CONCENTRATION BY 
TREATMENT DURING PERIODS 4 AND 7 
       
  Sulfate  Organic-Chelate 
    Mean SEM   Mean SEM 
Plasma Cu (ppm)      
 d 29 0.91 0.06 0.81 0.06 
 Normalized -0.21 0.07 0.03 0.07 
   
Plasma Zn (ppm)  
 d 29 0.46 0.03 0.43 0.02 
 Normalized -0.25 0.07 -0.40 0.07 
       
Ceruloplasmin (mg/100 ml)      
 d 23 26.92 4.09  31.54 5.87 
 Normalized 0.56 3.58  6.17 5.23 
 
  
d 29 
Normalized 
36.62
10.26
2.48
3.00
 
  
42.20
16.82
3.18 
2.50 
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APPENDIX 7. STANDARD EXERCISE TEST HEART RATE 
            
 Period 4  Period 7  Treadmill  Trojan 
  Mean SEM  Mean SEM  Mean SEM  Mean SEM 
36.78 3.71  33.88 2.68  37.43 4.82  34.00 2.12rest 
70.00 14.07  29.50 3.69  79.67 17.16  32.38 3.30walk 
82.22 9.61  45.88 5.23  87.00 11.74  49.80 5.05trot 1 
100.22 7.89  88.50 7.12  110.00 5.85  84.00 6.40lope 1 
93.22 9.28  71.57 8.82  104.29 7.34  67.78 7.29lope 2 
93.89 10.16  73.71 9.00  103.71 10.22  70.56 7.19lope 3 
77.44 7.14  31.43 4.15  82.86 8.09  37.44 5.09trot 2 
64.29 12.56  25.86 1.44  70.60 17.00  30.89 3.781 min post 
57.11 7.32  25.29 1.23  59.57 9.16  30.44 3.812 min post 
38.78 4.44  24.14 1.53  37.71 5.35  28.22 3.345 min post 
 
 
 
 
APPENDIX 8. SUPEROXIDE DISMUTASE ACTIVITY 
            
 Sulfate  Organic-Chelate  Period 4  Period 7 
  Mean SEM  Mean SEM  Mean SEM  Mean SEM 
1793.47 323.00  1355.70 148.32  1596.89 223.03  1504.64 300.95rest 
1675.51 240.64  1567.48 180.03  1742.10 217.76  1451.00 159.17final lope 
1822.60 381.05  1324.92 171.00  1275.05 163.61  1562.15 205.44final trot 
1476.16 213.40  1589.14 239.35  1378.22 153.00  1747.35 303.3830 min post 
1799.59 376.13  1520.79 187.04  1363.32 134.33  1665.15 265.3960 min post 
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APPENDIX 9. MEAN WHITE BLOOD CELL COUNTS BY DAY OF PERIODS 4 AND 7 
            
  Sulfate Organic-Chelate Period 4 Period 7 Total 
    Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
          d 1 
Total White Blood Cell 
Count  8162.50 415.30 8411.11 377.29 8466.67 299.54 8100.00 484.40 8294.12 272.31
Absolute Lymphocyte 
Count  2785.75 348.35 2705.22 299.36 2615.00 230.96 2887.25 403.57 2743.12 220.92
 Differential Neutrophil 61.00 3.81 62.56 4.02 65.00 2.60 58.25 4.82 61.82 2.70
Differential 
Lymphocyte  33.88 3.47 32.00 3.42 30.89 2.39 35.13 4.31 32.88 2.37
 Differential Monocyte 3.50 1.04 4.00 1.00 2.00 0.55 5.75 0.96 3.76 0.70
 Differential Eosinophil 1.38 0.56 1.33 0.58 1.89 0.68 0.75 0.25 1.35 0.39
 Differential Basophil 0.25 0.25 0.11 0.11 0.22 0.22 0.13 0.13 0.18 0.13
            
          d 23 
Total White Blood Cell 
Count  6275.00 421.20 6588.89 382.04 7022.22 382.52 5787.50 262.84 6441.18 276.94
Absolute Lymphocyte 
Count  2034.38 423.20 1959.89 409.68 2695.56 302.81 1206.75 331.34 1994.94 285.29
 Differential Neutrophil 63.75 4.72 66.00 5.40 56.11 3.58 74.88 4.12 64.94 3.52
Differential 
Lymphocyte  31.13 5.44 28.44 5.12 38.22 3.57 20.13 4.77 29.71 3.63
 Differential Monocyte 2.63 0.68 2.56 0.83 3.33 0.69 1.75 0.75 2.59 0.53
 Differential Eosinophil 2.00 0.57 2.67 0.55 1.89 0.56 2.88 0.52 2.35 0.39
  Differential Basophil 0.25 0.16 0.33 0.17 0.44 0.18 0.13 0.13 0.29 0.11
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APPENDIX 9. CONTINUED 
            
  Sulfate Organic-Chelate Period 4 Period 7 Total 
    Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
          d 29 
Total White Blood Cell 
Count  7787.50 445.39 7377.78 542.82 8222.22 457.78 6837.50 419.58 7570.59 348.50
Absolute Lymphocyte 
Count  2015.25 365.08 2015.33 282.63 2015.33 220.71 2015.25 416.36 2015.29 220.42
 Differential Neutrophil 69.63 3.79 68.56 4.36 70.89 3.87 67.00 4.29 69.06 2.83
Differential 
Lymphocyte  25.63 4.30 27.89 4.29 25.56 3.46 28.25 5.15 26.82 2.96
 Differential Monocyte 2.13 0.61 1.11 0.61 1.78 0.70 1.38 0.53 1.59 0.44
 Differential Eosinophil 2.00 0.96 1.89 0.42 1.11 0.42 2.88 0.83 1.94 0.49
  Differential Basophil 0.63 0.26 0.56 0.24 0.67 0.24 0.50 0.27 0.59 0.17
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APPENDIX 10. NORMALIZED WHITE BLOOD CELL COUNTS BY DAY OF PERIODS 4 AND 7 
           
  Sulfate Organic-Chelate Period 4 Period 7 Total 
    Mean SEM Mean SEM Mean SEM Mean SEM Mean 
d 23           
 
Total White Blood 
Cell Count -1887.50 495.13 -1822.22 491.81 -1444.44 547.24 -2312.50 338.29 -1852.94 338.48
 
Absolute 
Lymphocyte Count -751.38 527.30 -745.33 500.39 80.56 351.41 -1680.50 454.58 -748.18 351.46
 
Differential 
Neutrophil 2.75 6.39 3.44 7.16 -8.89 3.99 16.63 6.10 3.12 4.69
 
Differential 
Lymphocyte -2.75 7.11 -3.56 6.16 7.33 3.57 -15.00 6.73 -3.18 4.53
 
Differential 
Monocyte -0.88 1.02 -1.44 1.69 1.33 1.04 -4.00 1.10 -1.18 0.99
 
Differential 
Eosinophil 0.63 0.82 1.33 0.67 0.00 0.71 2.13 0.55 1.00 0.51
 
Differential  
Basophil 0.22 0.22 0.00 0.33 0.22 0.32 0.00 0.19 0.12 0.19
 
 
0.12
           
d 29          
 
Total White Blood 
Cell Count -375.00 351.91 -1033.33 418.66 -244.44 388.41 -1262.50 331.09 -723.53 280.43
 
Absolute 
Lymphocyte Count -770.50 265.48 -689.89 224.66 -599.67 233.04 -872.00 245.82 -727.82 167.25
 
Differential 
Neutrophil 8.63 3.63 6.00 3.84 5.89 4.16 8.75 3.11 7.24 2.59
 
Differential 
Lymphocyte -8.25 3.43 -4.11 2.69 -5.33 2.96 -6.88 3.30 -6.06 2.14
 
Differential 
Monocyte -1.38 1.46 -2.89 1.41 -0.22 1.09 -4.38 1.43 -2.18 1.00
 
Differential 
Eosinophil 0.63 1.03 0.56 0.93 -0.78 0.91 2.13 0.69 0.59 0.67
0.410.180.380.180.440.180.440.18  
Differential  
Basophil 0.38
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APPENDIX 11. ANOVA TABLE FOR COPPER AND ZINC BALANCE 
      
Source Partial SS df MS F-value P-value 
Cu Intake      
Model 2505.0526 3 835.0175 77.93 0.0000
Period 0.5902 1 0.5902 0.06 0.8184
Diet 2478.7353 1 2478.7353 231.32 0.0000
Period*Diet 2.7370 1 2.7370 0.26 0.6224
Residual 128.5851 12 10.7154   
Total 2633.6377 15 175.5758   
      
Cu Urine        
Model 17.3029 3 5.7676 0.37 0.7763
Period 11.1460 1 11.1460 0.71 0.4145
Diet 0.0732 1 0.0732 0.00 0.9465
Period*Diet 4.1165 1 4.1165 0.26 0.6168
Residual 187.2169 12 15.6014   
Total 204.5198 15 13.6347   
      
Cu Fecal      
Model 2554.8064 3 851.6021 38.12 0.0000
Period 4.3626 1 4.3626 0.20 0.6664
Diet 2481.4117 1 2481.4117 111.07 0.0000
Period*Diet 2.6790 1 2.6790 0.12 0.7351
Residual 268.0996 12 22.3416   
Total 2822.9059 15 188.1937   
      
Cu Absorption      
Model 11.8680 3 3.9560 0.77 0.5338
Period 1.7435 1 1.7435 0.34 0.5715
Diet 0.0007 1 0.0007 0.00 0.9908
Period*Diet 10.8315 1 10.8315 2.10 0.1727
Residual 61.8317 12 5.1526   
Total 73.6997 15 4.9133   
      
Cu Absorption as a 
Percent of Intake      
Model 2350.2422 3 783.4141 7.10 0.0053
Period 427.6086 1 427.6086 3.87 0.0726
Diet 1598.7300 1 1598.7305 14.48 0.0025
Period*Diet 709.5684 1 709.5684 6.43 0.0262
Residual 1324.5855 12 110.3821   
Total 3674.8277 15 244.9885   
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APPENDIX 11. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Cu Retention      
Model 22.4377 3 7.4792 0.40 0.7541
Period 21.7057 1 21.7057 1.17 0.3012
Diet 0.0885 1 0.0885 0.00 0.9461
Period*Diet 1.9532 1 1.5932 0.09 0.7748
Residual 223.1690 12 18.5974   
Total 245.6066 15 16.3738   
      
Cu Retention as a 
Percent of Intake      
Model 8020.7121 3 2673.5707 6.94 0.0058
Period 1065.4861 1 1065.4861 2.77 0.1221
Diet 7019.1655 1 7019.1655 18.23 0.0011
Period*Diet 605.0330 1 605.0330 1.57 0.2339
Residual 4620.6120 12 385.0510   
Total 12641.3241 15 842.7549   
      
Cu Retention as a 
Percent of Absorbed      
Model 365823.9840 3 121941.3280 0.55 0.6606
Period 1519.9720 1 1519.9720 0.01 0.9357
Diet 175960.2370 1 175960.2370 0.79 0.3925
Period*Diet 142852.7560 1 142852.7560 0.64 0.4397
Residual 2683683.3600 12 223640.2800   
Total 3049507.3500 15 203300.4900   
      
Zn Intake      
Model 24627.1389 3 8209.0463 51.87 0.0000
Period 82.8944 1 82.8944 0.52 0.4831
Diet 24345.3093 1 24345.3093 153.82 0.0000
Period*Diet 89.7097 1 89.7097 0.57 0.4660
Residual 1899.2044 12 158.2670   
Total 26526.3433 15 1768.4229   
      
Zn Urine        
Model 15.7440 3 5.2480 2.17 0.1441
Period 14.7963 1 14.7963 6.13 0.0292
Diet 0.3007 1 0.3007 0.12 0.7303
Period*Diet 1.9915 1 1.9915 0.83 0.3816
Residual 28.9645 12 2.4137   
Total 44.7085 15 2.9806   
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APPENDIX 11. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Zn Fecal      
Model 26654.3076 3 8884.7692 50.24 0.0000
Period 85.9817 1 85.9817 0.49 0.4989
Diet 24998.2237 1 24998.2237 141.37 0.0000
Period*Diet 357.1894 1 357.1894 2.02 0.1807
Residual 2121.9984 12 176.8332   
Total 28775.3059 15 1918.4204   
      
Zn Absorption      
Model 1328.3539 3 442.7846 2.36 0.1232
Period 337.7250 1 337.7250 1.80 0.2049
Diet 4.3199 1 4.3199 0.02 0.8820
Period*Diet 804.9098 1 804.9098 4.28 0.0607
Residual 2254.7963 12 187.8997   
Total 3583.1502 15 238.8767   
      
Zn Absorption as a 
Percent of Intake      
Model 1622.6796 3 540.8932 1.47 0.2726
Period 97.2901 1 97.2901 0.26 0.6167
Diet 808.8244 1 808.8244 2.20 0.1642
Period*Diet 801.0528 1 801.0528 2.17 0.1661
Residual 4420.8206 12 368.4017   
Total 6043.5002 15 402.9000   
      
Zn Retention      
Model 1431.6524 3 477.2175 2.43 0.1153
Period 493.9012 1 493.9012 2.52 0.1384
Diet 6.9000 1 6.9000 0.04 0.8543
Period*Diet 726.8265 1 726.8265 3.71 0.0782
Residual 2352.1035 12 196.0086   
Total 3783.7559 15 252.2504   
      
Zn Retention as a 
Percent of Intake      
Model 1990.4274 3 663.4758 1.59 0.2430
Period 236.4074 1 236.4074 0.57 0.4659
Diet 1200.7829 1 1200.7829 2.88 0.1154
Period*Diet 614.2778 1 614.2778 1.47 0.2481
Residual 5002.5537 12 416.8795   
Total 6992.9811 15 466.1987   
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APPENDIX 11. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Zn Retention as a 
Percent of Absorbed      
Model 53020.1238 3 17673.3746 0.53 0.6684
Period 6368.6072 1 6368.6072 0.19 0.6691
Diet 14817.1554 1 14817.1554 0.45 0.5166
Period*Diet 28385.7260 1 28385.7260 0.86 0.3732
Residual 398066.0510 12 33172.1709   
Total 451086.1740 15 30072.4116     
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APPENDIX 12. ANOVA TABLE FOR COPPER AND ZINC BALANCE ADJUSTED FOR 
TRUE ABSORPTION 
      
Source Partial SS df MS F-value P-value 
Cu Fecal - Adjusted      
Model 2554.7991 3 851.5997 38.12 0.0000
Period 4.3625 1 4.3625 0.20 0.6664
Diet 2481.4055 1 2481.4055 111.07 0.0000
Period*Diet 2.6789 1 2.6789 0.12 0.7351
Residual 268.1002 12 22.3417   
Total 2822.8993 15 188.1933   
      
True Cu Absorption      
Model 11.8680 3 3.9560 0.77 0.5338
Period 1.7433 1 1.7433 0.34 0.5716
Diet 0.0007 1 0.0007 0.00 0.9908
Period*Diet 10.8316 1 10.8316 2.10 0.1727
Residual 61.8315 12 5.1526   
Total 73.6995 15 4.9133   
      
True Cu Absorption as a 
Percent of Intake      
Model 1037.2356 3 345.7452 3.86 0.0382
Period 404.8029 1 404.8029 4.52 0.0550
Diet 48.8752 1 48.8752 0.55 0.4744
Period*Diet 635.5339 1 635.5339 7.09 0.0207
Residual 1075.1327 12 89.5943   
Total 2112.3682 15 140.8246   
      
Cu Retention      
Model 22.4376 3 7.4792 0.40 0.7541
Period 21.7057 1 21.7057 1.17 0.3012
Diet 0.0885 1 0.0885 0.00 0.9461
Period*Diet 1.5932 1 1.5932 0.09 0.7748
Residual 223.1696 12 18.5975   
Total 245.6072 15 16.3738   
      
Cu Retention as a Percent of 
Intake      
Model 2529.1718 3 843.0573 2.09 0.1553
Period 1029.3086 1 1029.3086 2.55 0.1363
Diet 1354.6282 1 1354.6282 3.35 0.0919
Period*Diet 536.8233 1 536.8233 1.33 0.2714
Residual 4845.5241 12 403.7937   
Total 7374.6959 15 491.6464   
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APPENDIX 12. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Cu Retention as a Percent 
of Absorbed      
Model 20686669.1000 3 6895556.3700 0.54 0.6638
Period 386588.2650 1 386588.2650 0.03 0.8647
Diet 4550359.3100 1 4550359.3100 0.36 0.5616
Period*Diet 18133876.3000 1 18133876.3000 1.42 0.2563
Residual 153175021.0000 12 12764585.1000   
Total 173861690.0000 15 11590779.3000   
      
Zn Fecal - Adjusted      
Model 26654.3085 3 8884.7695 50.24 0.0000
Period 85.9817 1 85.9817 0.49 0.4989
Diet 24998.2242 1 24998.2242 141.37 0.0000
Period*Diet 357.1896 1 357.1896   
Residual 2121.9981 12 176.8332   
Total 28776.3066 15 1918.4204   
      
True Zn Absorption      
Model 1328.3539 3 442.7846 2.36 0.1232
Period 337.7251 1 337.7251 1.80 0.2049
Diet 4.3199 1 4.3199 0.02 0.8820
Period*Diet 804.9097 1 804.9097 4.28 0.0607
Residual 2254.7964 12 187.8997   
Total 3583.1502 15 238.8767   
      
True Zn Absorption as a 
Percent of Intake      
Model 948.2040 3 316.0680 0.96 0.4446
Period 89.1110 1 89.1110 0.27 0.6130
Diet 58.8333 1 58.8333 0.18 0.6805
Period*Diet 757.5451 1 757.5451 2.29 0.1559
Residual 3965.4192 12 330.4516   
Total 4913.6231 15 327.5749   
      
Zn Retention      
Model 1431.6525 3 477.2175 2.43 0.1153
Period 493.9012 1 493.9012 2.52 0.1384
Diet 6.8999 1 6.8999 0.04 0.8543
Period*Diet 726.8266 1 726.8266 3.71 0.0782
Residual 2352.1033 12 196.0086   
Total 3783.7558 15 252.2504   
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APPENDIX 12. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Zn Retention as a Percent of 
Intake      
Model 1032.2384 3 344.0795 0.91 0.4653
Period 223.5573 1 223.5573 0.59 0.4570
Diet 192.7312 1 192.7312 0.51 0.4891
Period*Diet 576.2539 1 576.2539 1.52 0.2408
Residual 4540.3528 12 378.3627   
Total 5572.5912 15 371.5061   
      
Zn Retention as a Percent of 
Absorbed      
Model 155432.0710 3 51810.6902 0.98 0.4338
Period 41187.6062 1 41187.6062 0.78 0.3944
Diet 109736.0480 1 109736.0480 2.08 0.1749
Period*Diet 362.6196 1 362.6196 0.01 0.9353
Residual 633307.0730 12 52775.5894   
Total 788739.1440 15 52582.6096     
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APPENDIX 13. ANOVA TABLE FOR PLASMA COPPER, ZINC AND 
CERULOPLASMIN 
      
Source Partial SS df MS F-value P-value 
Cu d0-d85      
Model 0.2591 3 0.0864 2.61 0.0687
Day 0.2591 3 0.0864 2.61 0.0687
Residual 1.0600 32 0.3300   
Total 1.3190 35 0.0377   
      
Cu d57 & d141      
Model 0.0103 2 0.0052 0.18 0.8362
Diet history 0.0103 2 0.0052 0.18 0.8362
Residual 0.4275 15 0.0285   
Total 0.4378 17 0.0258   
      
Cu d85 & d169      
Model 0.1353 2 0.0676 3.27 0.0682
Diet history 0.1353 2 0.0676 3.27 0.0682
Residual 0.2892 14 0.0207   
Total 0.4245 16 0.0265   
      
Cu periods 4 & 7      
Model 0.1767 3 0.0589 2.04 0.1287
Diet 0.0005 1 0.0005 0.02 0.9004
Day 0.1194 1 0.1194 4.15 0.0506
Diet*day 0.0667 1 0.0667 2.32 0.1385
Residual 0.8643 30 0.0288   
Total 1.0411 33 0.0315   
      
Cu periods 4 & 7      
Model 0.0940 1 0.0940 3.18 0.0842
Period 0.0940 1 0.0940 3.18 0.0842
Residual 0.9471 32 0.0296   
Total 1.0411 33 0.0315   
      
Cu periods 4 & 7 normalized     
Model 0.0667 1 0.0667 2.62 0.1153
Diet 0.0667 1 0.0667 2.62 0.1153
Residual 0.8146 32 0.0255   
Total 0.8813 33 0.0267   
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APPENDIX 13. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Zn d0-d85      
Model 0.1286 3 0.0429 4.62 0.0085
Day 0.1286 3 0.0429 4.62 0.0085
Residual 0.2968 32 0.0093   
Total 0.4255 32 0.0122   
      
Zn d57 & d141      
Model 0.0103 2 0.0052 0.18 0.8362
Diet history 0.0103 2 0.0052 0.18 0.8362
Residual 0.4275 15 0.0285   
Total 0.4378 17 0.0258   
      
Zn d85 & d169      
Model 0.0493 2 0.0246 7.02 0.0077
Diet history 0.0493 2 0.0246 7.02 0.0077
Residual 0.0492 14 0.0035   
Total 0.0984 16 0.0062   
      
Zn periods 4 & 7      
Model 0.0169 3 0.0056 1.03 0.3927
Diet 0.0130 1 0.0130 2.39 0.1326
Day 0.0030 1 0.0030 0.54 0.4667
Diet*day 0.0007 1 0.0007 0.13 0.723
Residual 0.1635 30 0.0055   
Total 0.1804 33 0.0055   
      
Zn periods 4 & 7      
Model 0.0180 1 0.0180 3.55 0.0685
Period 0.0180 1 0.0180 3.55 0.0685
Residual 0.1624 32 0.0051   
Total 0.1804 33 0.0055   
      
Zn periods 4 & 7 normalized     
Model 0.0460 1 0.0460 0.089 0.3536
Diet 0.0460 1 0.0460 0.089 0.3536
Residual 1.6600 32 0.0519   
Total 1.7060 33 0.0517   
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APPENDIX 13. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Cp d0-d85      
Model 373.8655 3 124.6218 2.14 0.1149
Day 373.8655 3 124.6218 2.14 0.1149
Residual 1865.4899 32 58.2965   
Total 2239.3555 33 63.9816   
      
Cp d57 & d141      
Model 120.6751 2 60.3376 0.71 0.5075
Diet history 120.6751 2 60.3376 0.71 0.5075
Residual 1274.9985 15 84.9999   
Total 1395.0000 17 82.0985   
      
Cp d85 & d169      
Model 263.4366 2 131.7183 5.44 0.0179
Diet history 263.4366 2 131.7183 5.44 0.0179
Residual 338.9361 14 24.2097   
Total 602.3727 16 37.6483   
      
Cp periods 4 & 7      
Model 1956.0676 5 391.2135 3.46 0.0099
Diet 120.0065 1 120.0065 1.06 0.3084
Day 1684.0703 2 842.0351 7.45 0.0016
Diet*day 106.5679 45 113.0622   
Residual 5087.7969 50 140.8773   
Total      
      
Cp periods 4 & 7      
Model 264.9742 1 264.9742 1.92 0.1726
Period 264.9742 1 264.9742 1.92 0.1726
Residual 6778.8903 49 138.3447   
Total 7043.8645 50 140.8773   
      
Cp periods 4 & 7 normalized     
Model 2045.25616 5 409.0512 5.06 0.0009
Diet 209.1952 1 209.1952 2.59 0.1147
Day 1684.07 2 842.0351 10.41 0.0002
Diet*day 106.56788 2 53.2894   
Residual 3638.1772 45 80.8484   
Total 5683.4334 50 113.6687     
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APPENDIX 13. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Cp, d 113 & d 197 dropped     
Model 980.4457 7 140.0637 1.52 0.176
day of trial 980.4457 7 140.0637 1.52 0.176
residual 5699.1581 62 91.9219   
total 6679.6038 69 96.8059     
 
 
 
 
APPENDIX 14. REGRESSION TABLE FOR HEART RATE 
      
Source SS df MS   
Model 93987.9358 6 15497.9893   
Residual 76875.8126 152 505.7619   
Total 169863.7480 158 1075.0870   
      
r-square 0.5474     
Adj. R-square 0.5296     
 
  Coefficient Std. Error t P>|t| 
time 20.4791 3.3598 6.10 0.0000
time*diet -0.3446 4.5585 -0.08 0.9400
time2 -2.4403 0.3613 -6.75 0.0000
time2*diet -0.0288 0.4877 -0.06 0.9530
diet -1.9784 8.8059 -0.22 0.8230
machine -30.6210 3.6144 -8.47 0.0000
intercept 57.2831 6.7583 8.48 0.0000
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APPENDIX 15.  REGRESSION TABLE FOR SUPEROXIDE DISMUTASE DURING SET 
      
Source SS df MS   
Model 1039101.8300 3 346367.2780   
Residual 30880965.4000 71 434943.1750   
Total 31920067.3000 74 431352.2600   
      
r-square 0.0326     
Adj. R-square -0.0083     
 
  Coefficient Std. Error t P>|t| 
time 9.6545 54.2356 0.18 0.8590
diet 234.2033 152.9969 1.53 0.1300
period 3.3170 51.5555 0.06 0.9490
intercept 1195.5210 389.8371 3.07 0.0030
 
 
 
 
APPENDIX 16. ANOVA TABLE FOR SUPEROXIDE DISMUTASE 
      
Source Partial SS df MS F-value P-value 
Resting SOD      
Model 924795.7550 3 308265.2520 0.75 0.5329
Day 87132.7485 1 87132.7485 0.21 0.6493
Diet 171485.419 1 171483.419 0.42 0.5242
Day*Diet 671131.0760 1 671131.0760 1.63 0.2125
Residual 11544705.7000 28 412310.9190   
Total 12469501.5000 31 402241.9840   
      
Resting SOD      
Model  16366.3223 1 16366.3223 0.04 0.8439
Period 16366.3223 1 16366.3223 0.04 0.8439
Residual 12453135.2000 30 415104.5060   
Total 12469501.5000 31 402241.9840     
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APPENDIX 17. ANOVA TABLE FOR WHITE BLOOD CELL COUNTS 
      
Source Partial SS df MS F-value P-value 
Total WBC      
Model 31040637.3000 5 6208127.4500 3.84 0.0055
Diet 32952.0697 1 32952.0697 0.02 0.8871
Day  29706116.6000 1 14853058.3000 9.20 0.0004
Diet*Day 1357096.9500 2 678548.4750 0.42 0.6595
Residual 72675833.3000 45 1615018.5200   
Total 103716471.0000 50 2074329.4100   
      
Total WBC      
Model  12588507.6000 1 12588507.6000 6.77 0.0122
Period 12588507.6000 1 12588507.6000 6.77 0.0122
Residual 91127963.0000 49 1859754.3500   
Total 103716471.0000 50 2074329.4100   
      
Change WBC      
Model 31504223.9000 5 6300844.7700 5.59 4.0000
Diet 496538.6710 1 49538.6710 0.44 0.5102
Day  29706116.6000 2 14853058.3000 13.18 0.0000
Diet*Day 1357096.9500 2 678548.4750 0.60 0.5519
Residual 50699305.6000 45 1126651.2300   
Total 82203529.4000 50 1644070.5900   
      
Lymphocyte Count      
Model 6227115.9700 5 1245423.1900 1.15 0.3466
Diet 3887.2617 1 33887.2617 0.03 0.8602
Day  6175327.9700 2 3087663.9800 2.86 0.0677
Diet*Day 17075.6541 2 8537.8271 0.01 0.9921
Residual 48576977.3000 45 1079488.3800   
Total 54804093.3000 50 1096081.8700   
      
Lymphocyte Count      
Model  2089708.5000 1 2089708.5000 1.94 0.1697
Period 2089708.5000 1 2089708.5000 1.94 0.1697
Residual 52714384.8000 49 1075803.7700   
Total 54804093.3000 50 1096081.8700   
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APPENDIX 17. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Lymphocyte Change      
Model 6203829.2400 5 1240765.8500 1.36 0.2588
Diet 10600.5231 1 10600.5231 0.01 0.9148
Day  6175327.9700 2 3087663.9800 3.37 0.0431
Diet*Day 17075.6541 2 8537.8271 0.01 0.9907
Residual 41179034.8000 45 915089.6610   
Total 47382864.0000 50 947657.2800   
      
Diff. Neutrophil      
Model 484.3374 5 96.8675 0.58 0.7135
Diet 10.5689 1 10.5689 0.06 0.8022
Day  456.4744 2 228.2372 1.37 0.2642
Diet*Day 25.9646 2 12.9823 0.08 92.5100
Residual 7489.8194 45 166.4404   
Total 7974.1569 50 159.4831   
      
Diff. Neutrophil      
Model  93.1985 1 93.1985 0.58 0.4502
Period 93.1985 1 93.1985 0.58 0.4502
Residual 7880.9583 49 160.8359   
Total 7974.1569 50 159.4831   
      
Change Diff. Neutrophil      
Model 479.0302 5 95.8060 0.55 0.7343
Diet 5.2617 1 5.2617 0.03 0.8623
Day  456.4744 2 228.2372 1.32 0.2772
Diet*Day 25.9646 2 12.9823 0.08 0.9278
Residual 7779.5972 45 172.8799   
Total 8258.6275 50 165.1725   
      
Diff. Lymphocyte      
Model 379.3031 5 75.8606 0.46 0.8039
Diet 7.4142 1 7.4142 0.04 0.8331
Day  323.6144 2 161.8072 0.98 0.3828
Diet*Day 59.6144 2 29.8072 0.18 0.8353
Residual 7422.7361 45 164.9497   
Total 7802.0392 50 156.0408   
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APPENDIX 17. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Diff. Lymphocyte      
Model  176.0392 1 176.0392 1.13 0.2927
Period 176.0392 1 176.0392 1.13 0.2927
Residual 7626.0000 49 155.6327   
Total 7802.0392 50 156.0409   
      
Change Diff. Lymphocyte      
Model 387.5752 5 77.5150 0.52 0.7621
Diet 15.6863 1 15.6863 0.10 0.7479
Day  323.6144 2 161.8072 1.08 0.3486
Diet*Day 59.6144 2 29.8072 0.20 0.8205
Residual 6748.1111 45 149.9558   
Total 7135.6862 50 142.7137   
      
Diff. Monocyte      
Model 45.7859 5 9.1572 1.61 0.1767
Diet 0.4804 1 0.4804 0.08 0.7726
Day  38.5997 2 19.2998 3.39 0.0424
Diet*Day 4.9526 2 2.4763 0.44 0.6496
Residual 255.8611 45 5.6858   
Total 301.6471 50 6.0329   
      
Diff. Monocyte      
Model  4.3924 1 4.3924 0.72 0.3990
Period 4.3924 1 4.3924 0.72 0.3990
Residual 297.2546 49 6.0664   
Total 301.6471 50 6.0329   
      
Change Diff. Monocyte      
Model 51.4330 5 10.2866 0.88 0.5042
Diet 6.1275 1 3.1275 0.52 0.4736
Day  38.5997 2 19.2998 1.65 0.2043
Diet*Day 4.9526 2 2.4763 0.21 0.8105
Residual 527.8611 45 11.7302   
Total 579.2941 50 11.5859   
      
Diff. Eosinophil      
Model 10.5302 5 2.1060 0.65 0.6661
Diet 0.3728 1 0.3728 0.11 0.7369
Day  8.2358 2 4.1179 1.26 0.2627
Diet*Day 1.5691 2 0.7846 0.24 0.7872
Residual 146.7639 45 3.2614   
Total 157.2941 50 3.1459   
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APPENDIX 17. CONTINUED 
      
Source Partial SS df MS F-value P-value 
Diff. Eosinophil      
Model  3.6645 1 3.6645 1.17 0.2849
Period 3.6645 1 3.6645 1.17 0.2849
Residual 153.6296 49 3.1353   
Total 157.2941 50 3.1459   
      
Change Diff. Eosinophil      
Model 10.7337 5 2.1467 0.50 0.7722
Diet 0.5763 1 0.5763 0.14 0.7149
Day  8.2358 2 4.1179 0.97 0.3886
Diet*Day 1.5692 2 0.7846 0.18 0.8326
Residual 191.9722 45 4.2660   
Total 202.7059 50 4.0541   
      
Diff. Basophil      
Model 1.6609 5 0.3322 0.94 0.4675
Diet 0.0221 1 0.0221 0.06 0.8043
Day  1.5212 2 0.7606 2.14 0.1293
Diet*Day 0.1095 2 0.0547 0.15 0.8576
Residual 15.9861 45 0.3552   
Total 17.6471 50 0.3529   
      
Diff. Basophil      
Model  0.4804 1 0.4804 1.37 0.2473
Period 0.4804 1 0.4804 1.37 0.2473
Residual 17.1667 49 0.3503   
Total 17.6471 50 0.3529   
      
Change Diff. Basophil      
Model 1.7590 5 0.3518 1.16 0.3438
Diet 0.1201 1 0.1209 0.40 0.5324
Day  1.5212 2 0.7606 2.51 0.0928
Diet*Day 0.1095 2 0.0547 0.18 0.8355
Residual 13.6528 45 0.3034   
Total 15.4118 50 0.3082     
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